Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
FOS,Proto-oncogene c-Fos,Lifestyle factors,X1050.Time spend outdoors in summer,46726,0.0424497688278195,0.0415234864014378,-0.0389362645189986,0.123835802174638,0.306649522522773
FOS,Proto-oncogene c-Fos,Lifestyle factors,X1060.Time spent outdoors in winter,44928,0.0488290606827261,0.0460436191981811,-0.0414164329457088,0.139074554311161,0.288935419711413
FOS,Proto-oncogene c-Fos,Physical activities,X1070.Time spent watching television (TV),47738,0.0441309470098725,0.0422484809803717,-0.0386760757116559,0.126937969731401,0.296241373673035
FOS,Proto-oncogene c-Fos,Physical activities,X1080.Time spent using computer,44957,-0.0417705870896991,0.0413748877899129,-0.122865367157928,0.0393241929785302,0.312719839295091
FOS,Proto-oncogene c-Fos,Physical activities,X1090.Time spent driving,41480,-0.0124186372503359,0.0484925223619144,-0.107463981079688,0.0826267065790164,0.797882650579432
FOS,Proto-oncogene c-Fos,Lifestyle factors,X1160.Sleep duration,48398,-0.026681452941713,0.0369326477940996,-0.0990694426181482,0.0457065367347223,0.470035613958521
FOS,Proto-oncogene c-Fos,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,34590,-0.00607199981503835,0.0164509690088823,-0.0383158990724477,0.026171899442371,0.712070065028107
FOS,Proto-oncogene c-Fos,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,34590,0.00218577121242846,0.0157994647141736,-0.0287811796273518,0.0331527220522087,0.889973211573706
FOS,Proto-oncogene c-Fos,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,34590,0.0239374080846594,0.0170919202466651,-0.00956275559880426,0.0574375717681231,0.161418099523297
FOS,Proto-oncogene c-Fos,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,34590,0.0112947058906664,0.0173577695046116,-0.0227265223383723,0.045315934119705,0.515267672293836
FOS,Proto-oncogene c-Fos,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,34590,0.0368941468971192,0.0173993419919449,0.00279143659290725,0.0709968572013311,0.034015008256147
FOS,Proto-oncogene c-Fos,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,34590,-0.065116184616456,0.0450027010686063,-0.153321478710924,0.0230891094780124,0.147971963626979
FOS,Proto-oncogene c-Fos,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,34590,-0.0195377044633275,0.0453774096637523,-0.108477427404282,0.0694020184776271,0.666805415734791
FOS,Proto-oncogene c-Fos,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,34590,0.0420215559191981,0.0306670727429872,-0.0180859066570568,0.102129018495453,0.170665884095055
FOS,Proto-oncogene c-Fos,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,34590,0.000485698044958157,0.0218846132522457,-0.0424081439294434,0.0433795400193597,0.982294354612836
FOS,Proto-oncogene c-Fos,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,34590,-0.00886521361770726,0.014102597694475,-0.0365063050988782,0.0187758778634637,0.529622675970024
FOS,Proto-oncogene c-Fos,Health and medical history,X120039#18.Location of pain during the past week_Upper back,34590,0.0184378758243712,0.0213872885578769,-0.0234812097490674,0.0603569613978099,0.388673519002508
FOS,Proto-oncogene c-Fos,Health and medical history,X120039#19.Location of pain during the past week_Lower back,34590,0.0200180854757864,0.0114690708975716,-0.00246129348345396,0.0424974644350268,0.0809726524253787
FOS,Proto-oncogene c-Fos,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,34590,-0.00796898859650266,0.0147946944793394,-0.0369665897760078,0.0210286125830025,0.590158696573078
FOS,Proto-oncogene c-Fos,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,34590,-0.0263563790884111,0.0212548133165265,-0.068015813188803,0.0153030550119807,0.215022169484569
FOS,Proto-oncogene c-Fos,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,34590,0.0179178475666708,0.0200247494412387,-0.0213306613381572,0.0571663564714987,0.37094188290944
FOS,Proto-oncogene c-Fos,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,34590,0.0137749123303358,0.0309920823919211,-0.0469695691578296,0.0745193938185012,0.656723869932285
FOS,Proto-oncogene c-Fos,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,34590,0.0559748342280075,0.0296951517448923,-0.00222766319198139,0.114177331647996,0.0594859224039128
FOS,Proto-oncogene c-Fos,Health and medical history,X120039#7.Location of pain during the past week_Left hip,34590,-0.00425715380999598,0.015451778356531,-0.0345426393887966,0.0260283317688047,0.782933285638124
FOS,Proto-oncogene c-Fos,Health and medical history,X120039#8.Location of pain during the past week_Right hip,34590,0.0203247395162503,0.0147365011171786,-0.00855880267341986,0.0492082817059205,0.167886969882125
FOS,Proto-oncogene c-Fos,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,34590,0.015078371659009,0.0186658452696194,-0.0215066850694451,0.051663428387463,0.419238191947351
FOS,Proto-oncogene c-Fos,Health and medical history,X120040.Fatigue severity over the past week,34597,0.0699432800193698,0.0714969013452878,-0.0701906466173943,0.210077206656134,0.327984574835007
FOS,Proto-oncogene c-Fos,Health and medical history,X120041.Waking unrefreshed severity over the past week,34595,0.107096235392076,0.0717518070778471,-0.0335373064805039,0.247729777264657,0.135602221694532
FOS,Proto-oncogene c-Fos,Health and medical history,X120042.Cognitive symptoms severity over the past week,34595,0.238521153268172,0.0764928762941546,0.0885951157316292,0.388447190804715,0.00182907998469058
FOS,Proto-oncogene c-Fos,Health and medical history,X120098.Mobility problems today,34599,0.0648821517850589,0.0797977796845043,-0.0915214963965696,0.221285799966687,0.416206781913269
FOS,Proto-oncogene c-Fos,Health and medical history,X120099.Self-care problems today,34599,0.0233404747823771,0.123609364897377,-0.218933880416482,0.265614829981236,0.850237473325158
FOS,Proto-oncogene c-Fos,Health and medical history,X120100.Problems doing usual activities,34599,0.109795433398906,0.0766308772829597,-0.0404010860756949,0.259991952873507,0.15197767018667
FOS,Proto-oncogene c-Fos,Health and medical history,X120101.Pain or discomfort today,34599,0.187757542793032,0.0718531297474943,0.0469254084879435,0.328589677098121,0.00899805789841278
FOS,Proto-oncogene c-Fos,Health and medical history,X120102.Anxiety or depression today,34599,0.0506916958604295,0.0904688897826895,-0.126627328113642,0.228010719834501,0.575283160770717
FOS,Proto-oncogene c-Fos,Health and medical history,X120103.Scale to indicate how health is today,34581,-0.00313208134917847,0.00501330564676644,-0.0129581604168407,0.00669399771848376,0.532159169644982
FOS,Proto-oncogene c-Fos,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,34577,0.0387619419576518,0.0924200258713155,-0.142381308750126,0.21990519266543,0.674932793774095
FOS,Proto-oncogene c-Fos,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",34567,0.046833280121917,0.096202144671502,-0.141722923434227,0.235389483678061,0.626404640566434
FOS,Proto-oncogene c-Fos,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",34581,0.0802252474443363,0.0725672273306724,-0.0620065181237816,0.222457013012454,0.268979387779681
FOS,Proto-oncogene c-Fos,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,34583,0.0553711181639994,0.0738688334901861,-0.0894117954767653,0.200154031804764,0.453536207925014
FOS,Proto-oncogene c-Fos,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,34591,0.036910556192455,0.107238983542319,-0.17327785155049,0.2470989639354,0.73071702395947
FOS,Proto-oncogene c-Fos,Health and medical history,X120109.Feeling bad about self over the last two weeks,34575,0.17146502363358,0.103089985241996,-0.0305913474407319,0.373521394707892,0.0963194830751341
FOS,Proto-oncogene c-Fos,Health and medical history,X120110.Trouble concentrating over the last two weeks,34586,0.0325950399325543,0.10354100664757,-0.170345333096683,0.235535412961792,0.752923269409076
FOS,Proto-oncogene c-Fos,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,34584,0.00945161315597524,0.146306329913625,-0.27730879347473,0.29621201978668,0.94849366090028
FOS,Proto-oncogene c-Fos,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,34563,0.442550182847933,0.209996931400473,0.0309561973030066,0.85414416839286,0.0351280948313712
FOS,Proto-oncogene c-Fos,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",32762,-0.0813231239064792,0.101701917637348,-0.280658882475682,0.118012634662723,0.423982908058764
FOS,Proto-oncogene c-Fos,Lifestyle factors,X1269.Exposure to tobacco smoke at home,46876,-0.0348437318944893,0.0929671364023286,-0.217059319243053,0.147371855454075,0.707816516187464
FOS,Proto-oncogene c-Fos,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,45411,0.00304693230360006,0.056712180744041,-0.10810894195472,0.11420280656192,0.957153937335984
FOS,Proto-oncogene c-Fos,Diet and food preferences,X1289.Cooked vegetable intake,48018,-0.00864901605448646,0.039144738963567,-0.0853727044230778,0.0680746723141048,0.825134040372198
FOS,Proto-oncogene c-Fos,Diet and food preferences,X1299.Salad  or  raw vegetable intake,47345,0.0363882894308708,0.0409808685909771,-0.0439342130074444,0.116710791869186,0.374588245869029
FOS,Proto-oncogene c-Fos,Diet and food preferences,X1309.Fresh fruit intake,47969,-0.0230402912048415,0.0402389711338498,-0.101908674627187,0.0558280922175041,0.566931566679916
FOS,Proto-oncogene c-Fos,Diet and food preferences,X1319.Dried fruit intake,46951,-0.0593107670962111,0.0401303679426591,-0.137966288263823,0.0193447540714007,0.139438300074838
FOS,Proto-oncogene c-Fos,Health and medical history,X134.Number of self-reported cancers,48577,-0.00892265172600104,0.0626295737027405,-0.131676616183373,0.11383131273137,0.886712571060239
FOS,Proto-oncogene c-Fos,Health and medical history,X135.Number of self-reported non-cancer illnesses,48578,0.00994232857337297,0.0399568560309461,-0.0683731092472814,0.0882577663940273,0.803497551743992
FOS,Proto-oncogene c-Fos,Health and medical history,"X136.Number of operations, self-reported",48578,0.0293960546149699,0.0390747752431305,-0.0471905048615659,0.105982614091506,0.451878246201449
FOS,Proto-oncogene c-Fos,Health and medical history,X137.Number of treatments or medications taken,48578,0.0569608099813659,0.0386538344525726,-0.0188007055456765,0.132722325508408,0.140601939625545
FOS,Proto-oncogene c-Fos,Diet and food preferences,X1438.Bread intake,48054,0.00324193465986826,0.00281543684602166,-0.00227632155833419,0.00876019087807071,0.249547160720468
FOS,Proto-oncogene c-Fos,Diet and food preferences,X1458.Cereal intake,47771,0.0596923004719889,0.0382012733660037,-0.0151821953253785,0.134566796269356,0.118169961362707
FOS,Proto-oncogene c-Fos,Diet and food preferences,X1488.Tea intake,47977,0.00106582610933523,0.00273186045435132,-0.00428862038119335,0.00642027259986382,0.696432558716235
FOS,Proto-oncogene c-Fos,Diet and food preferences,X1498.Coffee intake,47143,0.00975235007394913,0.0386398881157769,-0.0659818306329737,0.0854865307808719,0.800741944709483
FOS,Proto-oncogene c-Fos,Diet and food preferences,X1528.Water intake,47040,-0.0247354090140072,0.0385725668474275,-0.100337640034965,0.0508668220069506,0.521355865049037
FOS,Proto-oncogene c-Fos,Lifestyle factors,X1568.Average weekly red wine intake,42419,0.00269503662043701,0.0439940228004565,-0.0835332480684577,0.0889233213093317,0.95115374576975
FOS,Proto-oncogene c-Fos,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,42420,-0.0224956546110081,0.0455338267289895,-0.111741954999828,0.0667506457778115,0.621284230216856
FOS,Proto-oncogene c-Fos,Lifestyle factors,X1588.Average weekly beer plus cider intake,42460,-0.0091368344733446,0.0517890243067883,-0.11064332211465,0.0923696531679604,0.859963428343936
FOS,Proto-oncogene c-Fos,Lifestyle factors,X1598.Average weekly spirits intake,42406,0.00709444282233204,0.0476058482683129,-0.0862130197835613,0.100401905428225,0.881536490956716
FOS,Proto-oncogene c-Fos,Lifestyle factors,X1608.Average weekly fortified wine intake,42448,0.0490277215646513,0.0706301010633853,-0.0894072765195839,0.187462719648886,0.487601759955524
FOS,Proto-oncogene c-Fos,Lifestyle factors,X1737.Childhood sunburn occasions,43314,0.0104798455412813,0.0470262190003262,-0.0816915436993581,0.102651234781921,0.823654604486868
FOS,Proto-oncogene c-Fos,Health and medical history,X1807.Father's age at death,46820,0.00510566582942497,0.00262397972800206,-3.7334437459075e-05,0.010248666096309,0.0516980278808124
FOS,Proto-oncogene c-Fos,Health and medical history,X1845.Mother's age,32069,0.0170538710042805,0.0127814558381704,-0.00799778243853347,0.0421055244470944,0.18222213441305
FOS,Proto-oncogene c-Fos,Health and medical history,X1873.Number of full brothers,48233,-0.0264372061710807,0.0371410248087959,-0.0992336147963208,0.0463592024541593,0.476593607561102
FOS,Proto-oncogene c-Fos,Health and medical history,X1883.Number of full sisters,48237,-3.26211755926461e-05,0.0370938460527252,-0.0727365594389341,0.0726713170877488,0.999298331392938
FOS,Proto-oncogene c-Fos,Physical measures,X20015.Sitting height,48441,-0.00259231339075239,0.00351225696163791,-0.0094763370355627,0.00429171025405792,0.460477123649916
FOS,Proto-oncogene c-Fos,Cognitive function,X20016.Fluid intelligence score,35607,0.0406366657255723,0.0623771902354491,-0.081622627135908,0.162895958587053,0.514768618340454
FOS,Proto-oncogene c-Fos,Cognitive function,X20018.Prospective memory result,35892,-0.164132105647152,0.0768420105407389,-0.314742446307,-0.0135217649873038,0.0327181483233257
FOS,Proto-oncogene c-Fos,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),35493,-0.000627054846328012,0.00457900273523415,-0.00960190020738695,0.00834779051473093,0.891081525468912
FOS,Proto-oncogene c-Fos,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),35478,0.00235086534499165,0.00460721843981913,-0.00667928279705385,0.0113810134870372,0.609889362725379
FOS,Proto-oncogene c-Fos,Cognitive function,X20023.Mean time to correctly identify matches,48330,0.00233973942765965,0.00286869366932887,-0.00328290016422494,0.00796237901954424,0.41473254522399
FOS,Proto-oncogene c-Fos,Health and medical history,X20107#1.Illnesses of father_Heart disease,45731,0.00991783183050254,0.00598609579181728,-0.00181491592145932,0.0216505795824644,0.0975765790474671
FOS,Proto-oncogene c-Fos,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,45372,0.0119357675088608,0.0125201897756445,-0.0126038044514024,0.036475339469124,0.340441387350228
FOS,Proto-oncogene c-Fos,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,45336,-0.0136713384104918,0.0171316128150079,-0.0472492995279074,0.0199066227069237,0.42487168193081
FOS,Proto-oncogene c-Fos,Health and medical history,X20107#12.Illnesses of father_Severe depression,45348,-0.0198597924486651,0.0160017358809768,-0.0512231947753797,0.0115036098780495,0.214585953698364
FOS,Proto-oncogene c-Fos,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,45372,0.0190441015918324,0.0111281422572285,-0.00276705723233542,0.0408552604160001,0.0870364300151342
FOS,Proto-oncogene c-Fos,Health and medical history,X20107#2.Illnesses of father_Stroke,45509,0.00615647724894578,0.00753918041792251,-0.00862031637018234,0.0209332708680739,0.414170303577035
FOS,Proto-oncogene c-Fos,Health and medical history,X20107#3.Illnesses of father_Lung cancer,45470,-0.00919163944269866,0.00916214428055278,-0.0271494422325821,0.00876616334718479,0.315770005030582
FOS,Proto-oncogene c-Fos,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,45377,0.00639482683544062,0.0117908443049817,-0.0167152280023235,0.0295048816732047,0.587581238666235
FOS,Proto-oncogene c-Fos,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,45517,0.00973337564712781,0.0081069220730163,-0.00615619161598414,0.0256229429102397,0.229914010057161
FOS,Proto-oncogene c-Fos,Health and medical history,X20107#8.Illnesses of father_High blood pressure,45512,-0.00395189568649684,0.00752185926227722,-0.0186947398405602,0.0107909484675665,0.599320531432081
FOS,Proto-oncogene c-Fos,Health and medical history,X20107#9.Illnesses of father_Diabetes,45403,0.0273687448532534,0.0108334002180486,0.00613528042587805,0.0486022092806287,0.0115355529500614
FOS,Proto-oncogene c-Fos,Health and medical history,X20110#1.Illnesses of mother_Heart disease,46638,-0.00678292175132426,0.00652312570714053,-0.0195682481373197,0.00600240463467119,0.298434729031705
FOS,Proto-oncogene c-Fos,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,46505,-0.0111674050885122,0.00853716273119788,-0.0279002440416601,0.00556543386463563,0.190859045848565
FOS,Proto-oncogene c-Fos,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,46429,-0.00497282832257703,0.0189182035992559,-0.0420525073771186,0.0321068507319646,0.792662064681304
FOS,Proto-oncogene c-Fos,Health and medical history,X20110#12.Illnesses of mother_Severe depression,46449,-0.0171713634338608,0.0118549430797433,-0.0404070518701577,0.00606432500243611,0.147507733564515
FOS,Proto-oncogene c-Fos,Health and medical history,X20110#2.Illnesses of mother_Stroke,46588,0.000382720191368586,0.0071269585707991,-0.0135861186073976,0.0143515589901348,0.957174518229684
FOS,Proto-oncogene c-Fos,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,46468,0.00770212277553553,0.0137161429952274,-0.0191815174951102,0.0345857630461812,0.57443875027464
FOS,Proto-oncogene c-Fos,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,46454,-0.000114733118698716,0.0116268637561059,-0.0229033860806663,0.0226739198432689,0.992126770016376
FOS,Proto-oncogene c-Fos,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,46459,-0.0155726938586123,0.0102063127423734,-0.0355770668336641,0.00443167911643953,0.127080393221883
FOS,Proto-oncogene c-Fos,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,46502,-0.00397151139282196,0.0113196864801235,-0.026158096893864,0.0182150741082201,0.725705194460888
FOS,Proto-oncogene c-Fos,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,46623,-0.012210322818532,0.00634168425958713,-0.0246400239673227,0.00021937833025882,0.0541947208491637
FOS,Proto-oncogene c-Fos,Health and medical history,X20110#9.Illnesses of mother_Diabetes,46516,-0.02303999121559,0.0097471425136726,-0.0421443905423882,-0.00393559188879166,0.0181010725675176
FOS,Proto-oncogene c-Fos,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,43506,-0.00779791391224293,0.00825646967796259,-0.0239805944810496,0.00838476665656374,0.344950046995287
FOS,Proto-oncogene c-Fos,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,43347,-0.0268741591164099,0.0289743945782678,-0.0836639724898147,0.0299156542569949,0.353675498179567
FOS,Proto-oncogene c-Fos,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,43341,-0.0371840969108674,0.0307967247218186,-0.0975456773656318,0.023177483543897,0.227296678081822
FOS,Proto-oncogene c-Fos,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,43369,-0.0063248772733873,0.0127307110607303,-0.0312770709524186,0.018627316405644,0.619323395616333
FOS,Proto-oncogene c-Fos,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,43363,-0.00559074736873896,0.0173238002706068,-0.0395453958991282,0.0283639011616503,0.746911604921418
FOS,Proto-oncogene c-Fos,Health and medical history,X20111#2.Illnesses of siblings_Stroke,43392,0.0054345408498533,0.0137247649923104,-0.021465998535075,0.0323350802347816,0.692136030797248
FOS,Proto-oncogene c-Fos,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,43361,-0.0132129021420873,0.0155527698319122,-0.0436963310126352,0.0172705267284606,0.39558801235549
FOS,Proto-oncogene c-Fos,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,43355,-0.00697739353554785,0.0157534891394418,-0.0378542322488538,0.023899445177758,0.657836880315726
FOS,Proto-oncogene c-Fos,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,43375,0.0123387448871332,0.0126471891643455,-0.012449745874984,0.0371272356492504,0.329273598702427
FOS,Proto-oncogene c-Fos,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,43391,-0.00562873709639395,0.015089801174426,-0.0352047473982689,0.023947273205481,0.709142113439766
FOS,Proto-oncogene c-Fos,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,43533,-0.000248564775030626,0.00695967433456391,-0.0138895264707759,0.0133923969207146,0.971510106352241
FOS,Proto-oncogene c-Fos,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,43445,0.00737999593017367,0.00958241826212442,-0.0114015438635902,0.0261615357239375,0.44121771233479
FOS,Proto-oncogene c-Fos,Mental health,X20127.Neuroticism score,44424,0.0199948431540297,0.0387910540701774,-0.056035622823518,0.0960253091315773,0.606246189662077
FOS,Proto-oncogene c-Fos,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,35607,0.00451576828044112,0.0631464246513167,-0.11925122403614,0.128282760597022,0.942991989430726
FOS,Proto-oncogene c-Fos,Lifestyle factors,X20161.Pack years of smoking,35771,0.00248468019115159,0.00450984729560415,-0.00635462050823255,0.0113239808905357,0.581689728450553
FOS,Proto-oncogene c-Fos,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,35771,0.00215103706356315,0.00466136448539097,-0.00698523732780315,0.0112873114549294,0.644483285553127
FOS,Proto-oncogene c-Fos,Cognitive function,X20191.Fluid intelligence score,33504,0.0025160656960084,0.0748109614629306,-0.144113418771335,0.149145550163352,0.973171916250233
FOS,Proto-oncogene c-Fos,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,33505,-0.0133125104434723,0.0772630045292989,-0.164747999320898,0.138122978433954,0.863208830654823
FOS,Proto-oncogene c-Fos,Cognitive function,X20240.Maximum digits remembered correctly,32975,-0.00326324549180421,0.0817060681363031,-0.163407139038958,0.15688064805535,0.96814399993397
FOS,Proto-oncogene c-Fos,Physical measures,X20255.Spirometry QC measure,43528,-0.043405921986478,0.049235206388081,-0.139906926507117,0.0530950825341607,0.378006133302774
FOS,Proto-oncogene c-Fos,Eye measures,X20261.avMSE,33580,-0.00686325695417711,0.00510719096431073,-0.0168733512442261,0.00314683733587193,0.179069045190364
FOS,Proto-oncogene c-Fos,Eye measures,X20262.Myopia diagnosis,33580,0.043915853156086,0.0996749501964784,-0.151447049229012,0.239278755541184,0.659531076363594
FOS,Proto-oncogene c-Fos,NMR metabolomics,X20280.Glucose-lactate,40040,-0.00498804863159349,0.00355799460447563,-0.0119617180563657,0.00198562079317874,0.160965670035711
FOS,Proto-oncogene c-Fos,NMR metabolomics,X20281.Spectrometer-corrected alanine,40060,-0.00640775345589173,0.00364540890474241,-0.0135527549091869,0.000737247997403392,0.0788165314043559
FOS,Proto-oncogene c-Fos,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,35247,-0.000761325056108948,0.021274802689599,-0.042459938327723,0.0409372882155051,0.971454739731589
FOS,Proto-oncogene c-Fos,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,35247,-0.0279348306031723,0.0402426965998549,-0.106810515938888,0.0509408547325434,0.487609132166773
FOS,Proto-oncogene c-Fos,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),35247,0.00864203356660795,0.0640450731119379,-0.11688630973279,0.134170376866006,0.892666375103906
FOS,Proto-oncogene c-Fos,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),35247,-0.0144567877444702,0.0196205350791936,-0.0529130364996896,0.0239994610107493,0.461260837776235
FOS,Proto-oncogene c-Fos,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),35247,-0.0463739971233465,0.0409011654558676,-0.126540281416847,0.033792287170154,0.256920729904631
FOS,Proto-oncogene c-Fos,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,35251,-0.0769976202193205,0.0502821218095667,-0.175550578966071,0.0215553385274302,0.125744506524266
FOS,Proto-oncogene c-Fos,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,35251,-0.020833829248843,0.0321843408419161,-0.0839151372989986,0.0422474788013125,0.517444129992655
FOS,Proto-oncogene c-Fos,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,35251,-0.0150986226371719,0.0377680567029794,-0.0891240137750114,0.0589267685006677,0.689338336142474
FOS,Proto-oncogene c-Fos,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,35251,-0.00842756239794991,0.058717813628972,-0.123514477110735,0.106659352314835,0.885879156815288
FOS,Proto-oncogene c-Fos,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,35251,-0.118559007308656,0.0671828008389574,-0.250237296953012,0.0131192823357008,0.0776607873046156
FOS,Proto-oncogene c-Fos,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,35251,0.00654356382755624,0.0414570887779475,-0.0747123301772208,0.0877994578323333,0.874588578147057
FOS,Proto-oncogene c-Fos,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,35251,-0.100626421719112,0.0696021154749857,-0.237046568050084,0.0357937246118597,0.148302445217302
FOS,Proto-oncogene c-Fos,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,35251,-0.0834639705318122,0.0489242617441385,-0.179355523550324,0.0124275824866992,0.0880624666772377
FOS,Proto-oncogene c-Fos,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),35250,-0.0124871624061535,0.0696163857639883,-0.148935278503571,0.123960953691264,0.857652382557565
FOS,Proto-oncogene c-Fos,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),35250,0.00352983168146668,0.026504213838127,-0.0484184274412623,0.0554780908041957,0.89405543817426
FOS,Proto-oncogene c-Fos,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),35250,-0.0361824399375504,0.0502978832217452,-0.134766291052171,0.0624014111770702,0.471944999452942
FOS,Proto-oncogene c-Fos,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,35251,-0.126716546956073,0.0876939067767751,-0.298596604238552,0.0451635103264068,0.148513294150851
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20600.Liking for adding salt to foods,35135,0.0152350762285244,0.0633868367305855,-0.109003123763423,0.139473276220472,0.810066630082233
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20601.Liking for aniseed,35135,-0.0814819053626857,0.0627829056908602,-0.204536400516772,0.0415725897914002,0.194394211960191
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20602.Liking for apple juice,35135,-0.0743548528535935,0.0633127945538143,-0.198447930179069,0.0497382244718824,0.240280047465039
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20603.Liking for apples,35135,-0.0424262287560515,0.0648002051735882,-0.169434630896284,0.0845821733841814,0.51267106124727
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20604.Liking for asparagus,35135,-0.00608586452254817,0.0645490833065442,-0.132602067803375,0.120430338758278,0.924887743595422
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20605.Liking for aubergine,35135,-0.00743851151233228,0.0631794677033754,-0.131270268210948,0.116393245186284,0.90628065551694
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20606.Liking for avocados,35135,-0.0208248867939221,0.0641785078365752,-0.14661476215361,0.104964988565765,0.745583218197036
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20607.Liking for bacon,35135,-0.00143380739144392,0.0640681278642485,-0.127007338005371,0.124139723222483,0.982146051286525
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20608.Liking for baked or steamed fish,35135,-0.00713554743059413,0.0644259516178031,-0.133410412601488,0.1191393177403,0.911813747678969
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20609.Liking for bananas,35135,0.0641629478119042,0.0658102410738436,-0.0648251246928293,0.193151020316638,0.32961537134781
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20610.Liking for barbequed or grilled meat,35135,0.0156736116764592,0.0633659453907487,-0.108523641289408,0.139870864642327,0.804645375926146
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20611.Liking for beef steak,35135,0.0929856515322711,0.0636124175026633,-0.031694686772949,0.217665989837491,0.143861837218307
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20612.Liking for beetroot,35135,-0.0530565254296197,0.064862166366815,-0.180186371508577,0.0740733206493376,0.413396439252867
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20613.Liking for bell pepper,35135,0.0641313018919504,0.0634333249149005,-0.0601980149412545,0.188460618725155,0.312056077584934
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20614.Liking for bicycling,35135,-0.0514385129984877,0.0632334133647994,-0.175376003193495,0.0724989771965191,0.41598103308774
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20615.Liking for biscuits,35135,0.0498762651691376,0.0639690439830196,-0.0755030610375808,0.175255591375856,0.435602251821358
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20616.Liking for bitter foods,35135,-0.0917635939119317,0.0635808892405106,-0.216382136823332,0.0328549489994692,0.149000756625797
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20617.Liking for bitter or ale,35135,0.049983802970112,0.0645193982923402,-0.0764742176828749,0.176441823623099,0.438542102225026
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20618.Liking for black olives,35135,-0.00347993973687412,0.063192734016305,-0.127337698408832,0.120377818935084,0.956085611487214
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20619.Liking for black pepper,35135,0.0217307199090211,0.0642326551348057,-0.104165284155198,0.14762672397324,0.735139563096534
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20620.Liking for blue cheese,35135,-0.00658940780286009,0.06360212313171,-0.131249569141012,0.118070753535291,0.917487446921003
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20621.Liking for bolognese sauce,35135,0.0241812324681119,0.0635972990466444,-0.100469473663311,0.148831938599535,0.703792606281048
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20622.Liking for broad beans,35135,-0.0130978348370702,0.0640933581389933,-0.138720816789497,0.112525147115357,0.8380826568693
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20623.Liking for broccoli,35135,0.000212140991892978,0.0650379719507657,-0.127262284031608,0.127686566015394,0.997397572779046
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20624.Liking for brown rice,35135,0.00629472893796793,0.0634937429556977,-0.1181530072552,0.130742465131135,0.921030972409333
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20625.Liking for brussel sprouts,35135,-0.00345502027082677,0.0640711068755563,-0.129034389746917,0.122124349205264,0.956996910575922
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20626.Liking for burgers (meat),35135,0.0170796852582328,0.0637688214602802,-0.107907204803916,0.142066575320382,0.788833673543199
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20627.Liking for burn of spicy foods,35135,-0.0653571101427299,0.0632005575955849,-0.189230203030076,0.0585159827446165,0.301121117581971
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20628.Liking for butter on bread,35135,-0.0457218525001061,0.0649025383701732,-0.172930827705646,0.0814871227054333,0.481168152669928
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20629.Liking for butternut squash,35135,-0.00933473209838909,0.0639056401643235,-0.134589786820463,0.115920322623685,0.883870656860674
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20630.Liking for cabbage,35135,0.0365042912545438,0.0639980723555844,-0.0889319305624016,0.161940513071489,0.568430249929883
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20631.Liking for cake,35135,0.156433607240038,0.0637974628259712,0.031390580101134,0.281476634378941,0.0142337055114335
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20632.Liking for cake icing,35135,0.114811034387379,0.062888816316057,-0.00845104559209225,0.238073114366851,0.0679578839180544
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20633.Liking for capers,35135,-0.0958661427580054,0.0630324056347453,-0.219409657802106,0.0276773722860955,0.128337607091039
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20634.Liking for cauliflower,35135,0.105379206343974,0.0650591669948616,-0.0221367609659547,0.232895173653903,0.105340400034109
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20635.Liking for cereal or granola bar,35135,-0.021985514092983,0.0630095753379888,-0.145484281755441,0.101513253569475,0.727159215035493
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20636.Liking for cheesecake,35135,0.109020775442906,0.0633001180218413,-0.0150474558799033,0.233089006765715,0.0850702243277802
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20637.Liking for cherries,35135,0.0439492770167794,0.0673689489812436,-0.0880938629864581,0.175992417020017,0.514189745404547
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20638.Liking for chicken,35135,0.15110871971129,0.0670499280314355,0.0196908607696769,0.282526578652904,0.02425300415459
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20639.Liking for chilli pepper,35135,-0.00282538910176608,0.0628178915484131,-0.125948456536656,0.120297678333124,0.964126790305748
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20640.Liking for chips or french fries,35135,0.106841456362011,0.0643847904073017,-0.0193527328363004,0.233035645560322,0.0970839011780376
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20641.Liking for cigarette smoking,35135,-0.120832625489742,0.108842861553182,-0.334164634133978,0.092499383154495,0.266976532503005
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20642.Liking for cod,35135,0.0130529915622334,0.0659687979609104,-0.116245852441151,0.142351835565618,0.84315657479211
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20643.Liking for coffee with sugar,35135,0.0726306423495612,0.0692226024607533,-0.0630456584735153,0.208306943172638,0.294113615168943
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20644.Liking for coffee without sugar,35135,-0.0723995792695628,0.0643159622952422,-0.198458865368237,0.053659706829112,0.260343986070907
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20645.Liking for coriander,35135,-0.0404104907661954,0.063449934968386,-0.164772363304232,0.0839513817718412,0.524222493351144
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20646.Liking for corn flakes,35135,0.0527588866896291,0.0636309699931856,-0.0719578144970146,0.177475587876273,0.407059404635664
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20647.Liking for cream,35135,0.102670921665439,0.0641278663436858,-0.0230196963681848,0.228361539699063,0.109422543048494
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20648.Liking for croissant,35135,-0.00400448511638657,0.0627638488231572,-0.127021628809775,0.119012658577002,0.949129705201383
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20649.Liking for cucumber,35135,-0.0252721685619736,0.0638512124415813,-0.150420544947473,0.0998762078235258,0.692268443795297
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20650.Liking for curry,35135,0.0211158148669129,0.0641345737088251,-0.104587949602384,0.14681957933621,0.741984172792112
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20651.Liking for dairy products,35135,0.143297920983995,0.0646701716909808,0.0165443844696727,0.270051457498317,0.0267411623529216
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20652.Liking for dark chocolate,35135,-0.0448882215289167,0.0644459333734913,-0.17120225094096,0.0814258078831262,0.486127224971027
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20653.Liking for diet fizzy drinks,35135,-0.0516498161850484,0.0659904631475849,-0.180991123954315,0.0776914915842181,0.433842728055304
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20654.Liking for dried fruit,35135,0.0915974678244311,0.0642189032772701,-0.0342715825990184,0.21746651824788,0.15382519664365
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20655.Liking for eggs,35135,0.0681064095466711,0.0659323110529333,-0.0611209201170782,0.19733373921042,0.301657847241208
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20656.Liking for exercising alone,35135,-0.0628293660714225,0.0638780272610589,-0.188030299503098,0.0623715673602528,0.325360513421347
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20657.Liking for exercising with others,35135,-0.0320074697453653,0.0640653376995533,-0.15757553163649,0.0935605921457591,0.617370593199
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20658.Liking for extra virgin olive oil,35135,-0.00198507918145283,0.0639945286032128,-0.12741435524375,0.123444196880844,0.975255020720623
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20659.Liking for fatty foods,35135,0.0106942791109907,0.0640665696829256,-0.114876197467543,0.136264755689525,0.867435157182158
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20660.Liking for fresh tomatoes,35135,0.0286100510867202,0.069021207475356,-0.106671515564978,0.163891617738418,0.678514886836813
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20661.Liking for fried chicken,35135,0.0595184760229139,0.0629970806002672,-0.0639558019536097,0.182992753999438,0.344808920065144
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20662.Liking for fried or battered fish,35135,0.070769604549594,0.063765353994548,-0.0542104892797201,0.195749698378908,0.267111182264828
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20663.Liking for fruit,35135,-0.0234251430420295,0.0729746716988423,-0.16645549957176,0.119605213487701,0.748218859727658
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20664.Liking for garlic,35135,0.0451425789941676,0.0637491947718164,-0.0798058427585925,0.170091000746928,0.478893700881338
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20665.Liking for gherkins,35135,-0.0636550231473972,0.063317141314756,-0.187756620124319,0.0604465738295246,0.314775928011989
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20666.Liking for globe artichoke,35135,-0.0414022774985716,0.0636046902688229,-0.166067470425465,0.0832629154283213,0.515116111045323
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20667.Liking for goat's cheese,35135,0.000285889987940808,0.0634133910611187,-0.124004356491852,0.124576136467733,0.996403018075288
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20668.Liking for going to a cafe,35135,0.0913060517788451,0.0635594855261027,-0.0332705398523161,0.215882643410006,0.150900098561342
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20669.Liking for going to the gym,35135,-0.0819544531415466,0.0632331669014452,-0.205891460268379,0.0419825539852861,0.195002650173535
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20670.Liking for going to the pub,35135,0.0637357960819014,0.0633517477630988,-0.0604336295337723,0.187905221697575,0.314426706076366
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20671.Liking for grapefruit,35135,-0.152504966256059,0.063410020528473,-0.276788606491866,-0.0282213260202522,0.0162002043952744
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20672.Liking for green olives,35135,-0.0522332358642141,0.0634041908250648,-0.176505449881341,0.0720389781529129,0.410078588064804
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20673.Liking for haddock,35135,-0.00348688351247039,0.0657088438283407,-0.132276217416018,0.125302450391077,0.957681374899256
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20674.Liking for ham,35135,-0.00867153574847809,0.0641407859595832,-0.134387476229261,0.117044404732305,0.892462013691033
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20675.Liking for hard cheese,35135,0.0954618910811374,0.0652699447453726,-0.032467200619793,0.223390982782068,0.1436379363626
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20676.Liking for herring,35135,-0.0293969140814295,0.0628449014261098,-0.152572920876605,0.0937790927137456,0.639966777637214
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20677.Liking for honey,35135,0.0342902448564077,0.0642114664116448,-0.091564229310416,0.160144719023231,0.59334730290944
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20678.Liking for horseradish or wasabi,35135,-0.0649057321454201,0.0635157163498945,-0.189396536191213,0.059585071900373,0.306877195512045
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20679.Liking for ice cream,35135,-0.0032428115577061,0.0634880473696501,-0.12767938440222,0.121193761286808,0.959265474461743
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20680.Liking for jam,35135,0.103230055989765,0.0636612188819963,-0.0215459330189474,0.228006044998478,0.104952186270318
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20681.Liking for kiwi fruit,35135,-0.0598361694684382,0.0646893754331952,-0.186627345317501,0.0669550063806245,0.35501561742612
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20682.Liking for lager,35135,-0.0240195240850955,0.0638382834209321,-0.149142559590122,0.101103511419931,0.706740195075257
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20683.Liking for lamb,35135,0.114482679762649,0.0642824444665376,-0.0115109113917649,0.240476270917062,0.0749746743177176
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20684.Liking for lemons,35135,-0.00829729883613923,0.0636836786777846,-0.133117309044597,0.116522711372319,0.896342001303115
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20685.Liking for lentils or beans,35135,-0.0584496045460331,0.0642051690946865,-0.184291735971619,0.0673925268795526,0.362671424576372
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20686.Liking for liver,35135,0.111381556487084,0.0631118027606655,-0.0123175769238198,0.235080689897989,0.077643914333065
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20687.Liking for mackerel,35135,-0.0430719933816138,0.0631550464457699,-0.166855884415323,0.0807118976520952,0.495263057996883
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20688.Liking for marzipan,35135,0.0454346743999289,0.0627709589958527,-0.0775964052319423,0.1684657540318,0.469206758798095
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20689.Liking for mayonnaise,35135,0.0502911433219389,0.0641030083904225,-0.0753507531232892,0.175933039767167,0.432756760900267
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20690.Liking for melon,35135,0.00889345384571057,0.0658869788523142,-0.120245024704825,0.138031932396246,0.89263191358496
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20691.Liking for milk chocolate,35135,0.128823893220551,0.0633521900300372,0.00465360076167765,0.252994185679423,0.0420508929862918
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20692.Liking for mushrooms,35135,0.0361652331947354,0.0654277498142182,-0.0920731564411322,0.164403622830603,0.58045497239466
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20694.Liking for orange juice,35135,0.0465084866738261,0.0636323314952917,-0.0782108830569455,0.171227856404598,0.464872793289122
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20695.Liking for oranges,35135,0.00398692277759124,0.0648602883941781,-0.123139242474998,0.13111308803018,0.950987457278561
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20696.Liking for pasta,35135,-0.0180242835366121,0.063853858092806,-0.143177845398512,0.107129278325288,0.777743272765262
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20697.Liking for pears,35135,-0.084859222456874,0.0653274354474569,-0.21290099593389,0.0431825510201415,0.194000280354278
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20698.Liking for pizza,35135,0.0432074351765273,0.0631387813209289,-0.0805445762124934,0.166959446565548,0.49379681061936
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20699.Liking for plain yogurt,35135,-0.0635963217506474,0.063590143592026,-0.188233003191018,0.0610403596897235,0.317304285365072
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20700.Liking for plums,35135,-0.11154225580817,0.0652797110660792,-0.239490489497685,0.0164059778813457,0.0875622141634163
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20701.Liking for pollock,35135,0.0410151227348396,0.0632419433167228,-0.0829390861659371,0.164969331635616,0.516658881054234
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20702.Liking for pork chop,35135,0.0896604113445214,0.0631762411735406,-0.0341650213556182,0.213485844044661,0.155890075226457
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20703.Liking for porridge,35135,0.032746162167446,0.0648722114624914,-0.0944033722990372,0.159895696633929,0.613732469628001
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20704.Liking for potato crisps,35135,0.0349574958828211,0.0636166112017164,-0.089731062072543,0.159646053838185,0.582681237876928
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20705.Liking for potatoes,35135,0.0979830920265801,0.0645774134542611,-0.0285886383437716,0.224554822396932,0.129245086120567
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20706.Liking for prawns,35135,-0.0437931284982167,0.0646801938520272,-0.17056630844819,0.0829800514517566,0.49838686868109
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20707.Liking for raw carrots,35135,-0.0902066959449224,0.0638924523360915,-0.215435902523662,0.0350225106338169,0.158045952276945
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20708.Liking for red meat,35135,0.114580543125885,0.0633653889854837,-0.00961561928566299,0.238776705537433,0.0706180278812477
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20709.Liking for red wine,35135,0.0123320168698889,0.0636101403811977,-0.112343858277259,0.137007892017036,0.846285310228095
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,35135,0.0127948316271288,0.065644464914793,-0.115868319605866,0.141457982860123,0.845469257905032
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20711.Liking for roast chicken,35135,0.134081979422989,0.0669023763432234,0.00295332179027089,0.265210637055706,0.0451000435685804
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20712.Liking for salad dressing,35135,0.0997329614595226,0.0639264264191157,-0.0255628343219443,0.225028757240989,0.118784630277777
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20713.Liking for salad leaves,35135,-0.00735993320516564,0.0649690745108806,-0.134699319246492,0.11997945283616,0.909809521088588
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20714.Liking for salami,35135,-0.0356673864623712,0.0629564693168492,-0.159062066323396,0.0877272933986532,0.57104787690868
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20715.Liking for salmon,35135,-0.0275811564773998,0.0669734803321567,-0.158849177928427,0.103686864973627,0.680484732196679
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20716.Liking for salty foods,35135,-0.00427651177400033,0.0633603233118575,-0.128462745465241,0.11990972191724,0.946189832252311
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20717.Liking for salty pretzels,35135,0.0116303952598601,0.0628158019639699,-0.111488576589521,0.134749367109241,0.853117096571935
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20718.Liking for sardines,35135,-0.0429662321261218,0.063102628492996,-0.166647383972394,0.0807149197201503,0.495964830611801
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20719.Liking for sausages (meat),35135,0.0825135155225582,0.0632688849009812,-0.041493498883365,0.206520529928481,0.192225505731419
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20720.Liking for savoury biscuits,35135,-0.0220533693229661,0.0641114742470151,-0.147711858847116,0.103605120201184,0.730869948394247
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20721.Liking for shellfish (other than prawns),35135,-0.0749656883874551,0.0626200424529562,-0.197700971595249,0.0477695948203391,0.231295281484523
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20722.Liking for skimmed milk,35135,-0.0152146862772897,0.0630481682634002,-0.138789096073554,0.108359723518975,0.809316652474611
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20723.Liking for smoked fish,35135,0.00932142930876967,0.0639175056609516,-0.115956881786696,0.134599740404235,0.884056354955246
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20724.Liking for soft cheese,35135,0.0254013646714907,0.063681400834709,-0.0994141809645389,0.15021691030752,0.689994508893294
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20725.Liking for soy sauce,35135,0.0372163981006805,0.0635657625992188,-0.0873724965937883,0.161805292795149,0.558248176718916
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20726.Liking for soya milk,35135,-0.0866288395444289,0.0636776509902328,-0.211437035485285,0.0381793563964275,0.173746311702401
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20727.Liking for spicy foods,35135,-0.00713009263736671,0.0635230713293383,-0.13163531244287,0.117375127168136,0.910633627871942
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20728.Liking for spinach,35135,-0.0192685783654708,0.0639213925627313,-0.144554507788424,0.106017351057483,0.763088205080663
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20729.Liking for spirits,35135,0.00216180583703406,0.0632236363431915,-0.121756521395621,0.126080133069689,0.972724398401612
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20730.Liking for strawberries,35135,-0.0451970683904389,0.0698473379625136,-0.182097850796966,0.0917037140160877,0.517602862932268
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20731.Liking for sweet coffee house drinks,35135,-0.0256357679790371,0.0646919366511659,-0.152431963815322,0.101160427857248,0.691916754286453
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20732.Liking for sweet foods,35135,0.0825064225009177,0.0634300496657724,-0.0418164748439962,0.206829319845832,0.193395726338552
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20733.Liking for taking the stairs,35135,0.00393165707162556,0.0645736295988953,-0.122632656942209,0.13049597108546,0.951451716528425
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20734.Liking for tea with sugar,35135,0.0942532404431454,0.0780704769681865,-0.0587648944145002,0.247271375300791,0.227370912746644
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20735.Liking for tea without sugar,35135,-0.0859516313550072,0.0667660858515242,-0.216813159623995,0.0449098969139802,0.198020927099496
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20736.Liking for tomato ketchup,35135,0.0312526121340211,0.0637144711605106,-0.0936277513405796,0.156132975608622,0.623790899515458
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20737.Liking for tinned tuna,35135,-0.000741950208494567,0.0637078358731037,-0.125609308519778,0.124125408102789,0.990708328480969
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20738.Liking for turnip (white),35135,0.0535123743406326,0.0634799969841454,-0.0709084197482923,0.177933168429557,0.399273560154614
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20739.Liking for vegetables,35135,0.00914839799037432,0.0701847560699483,-0.128413723906724,0.146710519887473,0.896296027907816
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20740.Liking for vinegar,35135,0.0185148558510234,0.0630903952735273,-0.10514231888509,0.142172030587137,0.769176614604538
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20741.Liking for watching television,35135,0.0530221927362285,0.0643218268913484,-0.0730485879708144,0.179092973443271,0.409787152489812
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20742.Liking for whisky,35135,0.0176230832548681,0.0654195474348614,-0.11059922971746,0.145845396227197,0.787642344839837
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20743.Liking for white bread,35135,0.0147536056036004,0.0635127583273041,-0.109731400717916,0.139238611925116,0.816318016775654
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20744.Liking for white rice,35135,0.0173286596091523,0.0636719671460051,-0.107468395997018,0.142125715215322,0.785512127032355
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20745.Liking for white wine,35135,-0.0814501439272939,0.0630598288745572,-0.205047408521426,0.0421471206668383,0.196534659151818
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,35135,0.0304391374188463,0.0646436681482703,-0.0962624521517635,0.157140726989456,0.63774676161733
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20747.Liking for whole milk,35135,-0.0202624254233823,0.0637757207524324,-0.14526283809815,0.104737987251385,0.75071323896692
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20748.Liking for wholemeal bread,35135,0.0131275682040511,0.0673187094104174,-0.118817102240367,0.145072238648469,0.845394743264466
FOS,Proto-oncogene c-Fos,Diet and food preferences,X20749.Liking for working up a sweat,35135,0.0269354517489333,0.0636717814107429,-0.0978612398161228,0.151732143313989,0.672284376096459
FOS,Proto-oncogene c-Fos,Physical measures,X21001.Body mass index (BMI),48492,-0.0153804289248185,0.0123315655983927,-0.0395502974976681,0.00878943964803109,0.212324436655106
FOS,Proto-oncogene c-Fos,Physical measures,X21002.Weight,48504,0.00145963278209813,0.00662484029007847,-0.0115250541864557,0.0144443197506519,0.825618635467559
FOS,Proto-oncogene c-Fos,Physical measures,X21021.Pulse wave Arterial Stiffness index,35858,-0.000299914915072257,0.00432756831596532,-0.00878194881436427,0.00818211898421976,0.94475025083939
FOS,Proto-oncogene c-Fos,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,34953,-0.0206924379967503,0.0693504769337355,-0.156619372786872,0.115234496793371,0.765427857647306
FOS,Proto-oncogene c-Fos,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,34967,0.019964414031663,0.0708010182415306,-0.118805581721737,0.158734409785063,0.777969577128811
FOS,Proto-oncogene c-Fos,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,34969,0.0142818837846579,0.0696722502052262,-0.122275726617585,0.150839494186901,0.837589754015112
FOS,Proto-oncogene c-Fos,Health and medical history,X21040.Satisfaction with bowel habits,34926,0.00265099230284069,0.0644060711968554,-0.123584907242996,0.128886891848677,0.967169302350283
FOS,Proto-oncogene c-Fos,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,34907,0.0659025152932651,0.0694897303085777,-0.0702973561115472,0.202102386698077,0.342977350514921
FOS,Proto-oncogene c-Fos,Health and medical history,X21042.Greatest number of times bowels opened per day,34929,0.0254001300644912,0.0693055434013575,-0.11043873500217,0.161238995131152,0.714009319635558
FOS,Proto-oncogene c-Fos,Health and medical history,X21043.Least number of times bowels opened per week,34872,0.0694712146763251,0.0693628422212574,-0.0664799560773393,0.20542238542999,0.31659767641344
FOS,Proto-oncogene c-Fos,Health and medical history,X21044.Average number of times bowels opened per day,34898,0.109852584735241,0.0787685398179673,-0.0445337533079748,0.264238922778457,0.163183299934045
FOS,Proto-oncogene c-Fos,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,34970,-0.106648858583101,0.0697097213161727,-0.243279912362799,0.0299821951965977,0.126096410459393
FOS,Proto-oncogene c-Fos,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,34966,0.016673446716988,0.0705178109973531,-0.121541462837824,0.1548883562718,0.813097280813351
FOS,Proto-oncogene c-Fos,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,32244,0.0388400370573519,0.119867019054362,-0.196099320289197,0.273779394403901,0.745940535149074
FOS,Proto-oncogene c-Fos,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,34969,0.00738193287049477,0.0803795782615204,-0.150162040522085,0.164925906263075,0.926829610108272
FOS,Proto-oncogene c-Fos,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,34968,0.0805933115306412,0.106055128253147,-0.127274739845528,0.28846136290681,0.447334009224372
FOS,Proto-oncogene c-Fos,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,34965,-0.0667936388404438,0.0808901848808307,-0.225338401206872,0.0917511235259844,0.408990101411153
FOS,Proto-oncogene c-Fos,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,34965,0.0946231136289044,0.203311821213118,-0.303868055948806,0.493114283206615,0.641656288060386
FOS,Proto-oncogene c-Fos,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,34971,0.0595025105379092,0.0829267690982654,-0.103033956894691,0.222038977970509,0.473075658969617
FOS,Proto-oncogene c-Fos,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,34968,-0.0296904647987278,0.0761640719054197,-0.17897204573335,0.119591116135895,0.696682225339107
FOS,Proto-oncogene c-Fos,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,34836,-0.0478962198637998,0.0735426337672691,-0.192039782047647,0.0962473423200477,0.514897789950369
FOS,Proto-oncogene c-Fos,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,34965,-0.0116661330542661,0.0701670781682706,-0.149193606264076,0.125861340155544,0.867956434393764
FOS,Proto-oncogene c-Fos,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,34967,-0.0418781693779765,0.111893645133452,-0.261189713839543,0.17743337508359,0.708218960509771
FOS,Proto-oncogene c-Fos,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,34972,0.0376541599981908,0.0704800568371702,-0.100486751402663,0.175795071399044,0.593187276911138
FOS,Proto-oncogene c-Fos,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,34971,0.0681700631039136,0.0704488206645499,-0.0699096253986043,0.206249751606431,0.333257855311359
FOS,Proto-oncogene c-Fos,Working and living environment,X21100.Water hardness (USGS classification),48460,-0.00707625988363124,0.0373977398918514,-0.08037583007166,0.0662233103043975,0.8499253299962
FOS,Proto-oncogene c-Fos,Lifestyle factors,X2139.Age first had sexual intercourse,45304,-0.00475969905581689,0.00306779192512279,-0.0107725712290576,0.00125317311742377,0.120799998691082
FOS,Proto-oncogene c-Fos,Health and medical history,X2149.Lifetime number of sexual partners,44307,0.000242074121894661,0.0421431103116343,-0.0823584220889086,0.0828425703326979,0.995416974552167
FOS,Proto-oncogene c-Fos,Physical activities,X22032.IPAQ activity group,44303,-0.00849495953795865,0.0421618149508648,-0.0911321168416537,0.0741421977657364,0.84032232468429
FOS,Proto-oncogene c-Fos,Physical activities,X22033.Summed days activity,44723,-0.00356750402716456,0.00300492946389868,-0.00945716577640597,0.00232215772207686,0.235160107328646
FOS,Proto-oncogene c-Fos,Physical activities,X22034.Summed minutes activity,44303,0.00165605124055731,0.00296529337824426,-0.00415592378080144,0.00746802626191607,0.576526270333186
FOS,Proto-oncogene c-Fos,Physical activities,X22037.MET minutes per week for walking,43472,0.00118690680881705,0.00317086969292222,-0.00502799778931049,0.00740181140694459,0.708174894122982
FOS,Proto-oncogene c-Fos,Physical activities,X22038.MET minutes per week for moderate activity,44303,-0.000394465449748779,0.00288837348439913,-0.00605567747917107,0.00526674657967351,0.89137243293959
FOS,Proto-oncogene c-Fos,Physical activities,X22039.MET minutes per week for vigorous activity,44303,-0.0250039085528133,0.0420877723887288,-0.107495942434722,0.0574881253290951,0.552461070752876
FOS,Proto-oncogene c-Fos,Physical activities,X22040.Summed MET minutes per week for all activity,43472,0.00157422143413115,0.00307742878015976,-0.00445753897498198,0.00760598184324428,0.608982372385818
FOS,Proto-oncogene c-Fos,Eye measures,X2217.Age started wearing glasses or contact lenses,46908,0.00295155893150914,0.00251375674643772,-0.00197540429150878,0.00787852215452706,0.240345724212697
FOS,Proto-oncogene c-Fos,Working and living environment,X22501.Year ended full time education,33347,-0.00499878536476025,0.0125765499217927,-0.0296488232114739,0.0196512524819534,0.691042265859226
FOS,Proto-oncogene c-Fos,Lifestyle factors,X22506.Tobacco smoking,33324,-0.0075301438569008,0.165021772061018,-0.330972817096495,0.315912529382694,0.963606396800208
FOS,Proto-oncogene c-Fos,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,47473,0.159749263834176,0.139032185559161,-0.11275381986178,0.432252347530132,0.250567212042653
FOS,Proto-oncogene c-Fos,Physical measures,X23098.Weight,48098,0.000570287621410936,0.00669993135893439,-0.0125615778421005,0.0137021530849223,0.932168141853903
FOS,Proto-oncogene c-Fos,Physical measures,X23099.Body fat percentage,48090,-0.012841826959749,0.00638310716670507,-0.0253527170064909,-0.000330936913007045,0.0442503679181185
FOS,Proto-oncogene c-Fos,Physical measures,X23100.Whole body fat mass,48077,-0.00923109152152442,0.00629252730132329,-0.0215644450321181,0.00310226198906923,0.142394699008664
FOS,Proto-oncogene c-Fos,Physical measures,X23101.Whole body fat-free mass,48097,0.00768046621904804,0.00545076270887362,-0.00300302869034425,0.0183639611284403,0.158833089189446
FOS,Proto-oncogene c-Fos,Physical measures,X23102.Whole body water mass,48098,0.00703890686534574,0.00546693358140601,-0.00367628295421004,0.0177540966849015,0.197921185557025
FOS,Proto-oncogene c-Fos,Physical measures,X23104.Body mass index (BMI),48098,-0.0185609414868017,0.012326706788571,-0.0427212867924009,0.00559940381879749,0.132148014203556
FOS,Proto-oncogene c-Fos,Physical measures,X23105.Basal metabolic rate,48098,0.00663383123411898,0.00582121123431974,-0.0047757427851477,0.0180434052533857,0.254468934582732
FOS,Proto-oncogene c-Fos,Physical measures,X23106.Impedance of whole body,48095,-0.00691295580971237,0.00445973533455899,-0.015654037065448,0.00182812544602326,0.121138560018269
FOS,Proto-oncogene c-Fos,Physical measures,X23107.Impedance of leg (right),48098,-0.00935911612843287,0.00361611166843829,-0.0164466949985719,-0.00227153725829383,0.00965608352005547
FOS,Proto-oncogene c-Fos,Physical measures,X23108.Impedance of leg (left),48098,-0.00791941936135252,0.0035838542034293,-0.014943773600074,-0.000895065122631094,0.0271345042189693
FOS,Proto-oncogene c-Fos,Physical measures,X23109.Impedance of arm (right),48096,-0.00173819752624727,0.00440020350897289,-0.0103625964038341,0.00688620135133961,0.692827698669175
FOS,Proto-oncogene c-Fos,Physical measures,X23110.Impedance of arm (left),48098,-0.00238069902070318,0.00441582518770384,-0.0110357163886027,0.00627431834719634,0.589804257698502
FOS,Proto-oncogene c-Fos,Physical measures,X23111.Leg fat percentage (right),48098,-0.01896159602102,0.00753779555496536,-0.0337356753087521,-0.00418751673328792,0.0118933747508261
FOS,Proto-oncogene c-Fos,Physical measures,X23112.Leg fat mass (right),48098,-0.0187613421616899,0.00826059506123013,-0.0349521084817009,-0.00257057584167882,0.0231469556806918
FOS,Proto-oncogene c-Fos,Physical measures,X23113.Leg fat-free mass (right),48097,0.0101672717987546,0.00556088853127808,-0.000732069722550462,0.0210666133200596,0.067512217532089
FOS,Proto-oncogene c-Fos,Physical measures,X23114.Leg predicted mass (right),48097,0.00995758444876435,0.00559150492201981,-0.00100176519839448,0.0209169340959232,0.074954389436138
FOS,Proto-oncogene c-Fos,Physical measures,X23115.Leg fat percentage (left),48095,-0.0192006310745498,0.0079020928024945,-0.034688732967439,-0.0037125291816606,0.015115740805625
FOS,Proto-oncogene c-Fos,Physical measures,X23116.Leg fat mass (left),48095,-0.0145327117370289,0.00862142897576932,-0.0314307125295368,0.00236528905547898,0.0918797392114902
FOS,Proto-oncogene c-Fos,Physical measures,X23117.Leg fat-free mass (left),48094,0.00854678273008374,0.00583910121681904,-0.00289785565488157,0.019991421115049,0.143288339942254
FOS,Proto-oncogene c-Fos,Physical measures,X23118.Leg predicted mass (left),48094,0.00871501916501159,0.00587469630015734,-0.0027993855832968,0.02022942391332,0.137962485067346
FOS,Proto-oncogene c-Fos,Physical measures,X23119.Arm fat percentage (right),48094,-0.0101885185010776,0.00718387533136663,-0.0242689141505562,0.00389187714840099,0.156134791999338
FOS,Proto-oncogene c-Fos,Physical measures,X23120.Arm fat mass (right),48092,-0.0104009076205709,0.00718677642585596,-0.0244869894152486,0.0036851741741068,0.147849525914526
FOS,Proto-oncogene c-Fos,Physical measures,X23121.Arm fat-free mass (right),48093,0.00256181208338328,0.0055690070807236,-0.00835344179483497,0.0134770659616015,0.645512641618419
FOS,Proto-oncogene c-Fos,Physical measures,X23122.Arm predicted mass (right),48093,0.00199011129997358,0.00558048090041706,-0.00894763126484386,0.012927853864791,0.721380257127301
FOS,Proto-oncogene c-Fos,Physical measures,X23123.Arm fat percentage (left),48092,-0.0135893455055234,0.00736702585036562,-0.0280287161722401,0.000850025161193174,0.0651088249615051
FOS,Proto-oncogene c-Fos,Physical measures,X23124.Arm fat mass (left),48092,-0.0144593353269139,0.00719680718619072,-0.0285650774118478,-0.000353593241980116,0.0445373343715102
FOS,Proto-oncogene c-Fos,Physical measures,X23125.Arm fat-free mass (left),48092,0.00450843719297169,0.00568838130524941,-0.00664079016531715,0.0156576645512605,0.42803866804657
FOS,Proto-oncogene c-Fos,Physical measures,X23126.Arm predicted mass (left),48090,0.00493256993972206,0.00569337685505247,-0.00622644869618078,0.0160915885756249,0.386298383488658
FOS,Proto-oncogene c-Fos,Physical measures,X23127.Trunk fat percentage,48090,-0.00671239716432213,0.00456206124447366,-0.0156540372034905,0.00222924287484623,0.141212645602924
FOS,Proto-oncogene c-Fos,Physical measures,X23128.Trunk fat mass,48090,-0.00478042433905471,0.00510407770895766,-0.0147844166486117,0.00522356797050231,0.348981850881924
FOS,Proto-oncogene c-Fos,Physical measures,X23129.Trunk fat-free mass,48089,0.00616754454104321,0.0049285394746335,-0.00349239282923845,0.0158274819113249,0.210806271688779
FOS,Proto-oncogene c-Fos,Physical measures,X23130.Trunk predicted mass,48086,0.00601015302343874,0.00495153342697521,-0.00369485249343268,0.0157151585403102,0.224840687984135
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23400.Total Cholesterol,40065,-0.00717595562589913,0.00357261447851809,-0.0141782800037946,-0.000173631248003668,0.0446041897097373
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,40065,-0.00517901176995284,0.00345650247680045,-0.0119537566244817,0.00159573308457603,0.134074283974917
FOS,Proto-oncogene c-Fos,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",40065,-0.00366310899838335,0.00345053428885064,-0.0104261562045306,0.0030999382077639,0.288438028103408
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23403.VLDL Cholesterol,40065,-0.00150043280201579,0.00349803932707073,-0.00835658988307442,0.00535572427904284,0.667978756743951
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23404.Clinical LDL Cholesterol,40065,-0.00633665500989744,0.00345281087081159,-0.0131041643166881,0.000430854296893273,0.0665009419069765
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23405.LDL Cholesterol,40065,-0.00650695678333464,0.00346761127104532,-0.0133034748745835,0.000289561307914194,0.060614045326269
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23406.HDL Cholesterol,40065,-0.00949833349598551,0.00402051422262138,-0.0173785413723234,-0.00161812561964761,0.0181712561008029
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23407.Total Triglycerides,40065,0.000299445513878993,0.00377049632981866,-0.00709072729256557,0.00768961832032356,0.93670156386539
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23408.Triglycerides in VLDL,40065,0.000435468353139032,0.00375541149745816,-0.00692513818187896,0.00779607488815702,0.907688319062153
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23409.Triglycerides in LDL,40065,0.000978576519170779,0.00375832387748598,-0.00638773828070175,0.00834489131904331,0.794578853337029
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23410.Triglycerides in HDL,40065,-0.000843785037973186,0.00368659514179461,-0.00806951151589062,0.00638194143994424,0.818967093626428
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,40065,-0.00707986982164935,0.00370962205932895,-0.0143507290579341,0.000190989414635396,0.0563509796077051
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23412.Phospholipids in VLDL,40065,-0.000570743599369858,0.00360864503829916,-0.00764368787443622,0.00650220067569651,0.874333594469888
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23413.Phospholipids in LDL,40065,-0.00618696819863712,0.0034491561544836,-0.012947314261425,0.000573377864150726,0.0728788090507598
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23414.Phospholipids in HDL,40065,-0.00806535855910665,0.00397557564631955,-0.015857486825893,-0.000273230292320335,0.0425104055321391
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23415.Total Esterified Cholesterol,40065,-0.00769460276641807,0.00359195622761898,-0.0147348369725513,-0.000654368560284865,0.0322014635043451
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,40065,-0.00174225439980361,0.00345739447214741,-0.00851874756521252,0.00503423876560531,0.614326958245365
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23417.Cholesteryl Esters in LDL,40065,-0.00625537468179645,0.00347136941625738,-0.0130592587376609,0.000548509374068014,0.0715745934021723
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23418.Cholesteryl Esters in HDL,40065,-0.00980883217934804,0.00399817342147519,-0.0176452520854394,-0.00197241227325667,0.0141696940267202
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23419.Total Free Cholesterol,40065,-0.00576749003739698,0.00352809027805719,-0.0126825469823891,0.00114756690759511,0.102133721627258
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23420.Free Cholesterol in VLDL,40065,-0.0011520821463377,0.00356834683502116,-0.00814604194297919,0.00584187765030378,0.746806273017954
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23421.Free Cholesterol in LDL,40065,-0.00709033675946472,0.00347449502864875,-0.0139003470156163,-0.000280326503313163,0.0413066300808202
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23422.Free Cholesterol in HDL,40065,-0.00751791277848274,0.00405607468764764,-0.0154678191662721,0.000431993609306641,0.0638385644687125
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,40065,-0.00575712224230404,0.00356566222465345,-0.0127458202026248,0.00123157571801672,0.106426123019905
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23424.Total Lipids in VLDL,40065,-0.00046188197201833,0.00365557786260023,-0.00762681458271479,0.00670305063867813,0.899457278717272
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23425.Total Lipids in LDL,40065,-0.00616501019725906,0.00346627420289907,-0.0129589076349412,0.000628887240423117,0.0753382782792123
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23426.Total Lipids in HDL,40065,-0.00876685310727096,0.00400444602828497,-0.0166155673227095,-0.000918138891832421,0.0285976914288991
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,40065,-0.0109520517511098,0.00378128975941752,-0.0183633796795681,-0.00354072382265146,0.00378247828406364
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23428.Concentration of VLDL Particles,40065,-0.000713888729255798,0.00356019271990948,-0.00769186646027837,0.00626408900176678,0.841077913823599
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23429.Concentration of LDL Particles,40065,-0.00382668289843042,0.00343137657722343,-0.0105521809897883,0.00289881519292751,0.264787912394166
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23430.Concentration of HDL Particles,40065,-0.0109240970915468,0.0037871078514472,-0.0183468284803833,-0.00350136570271029,0.00392745207120677
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23431.Average Diameter for VLDL Particles,40065,-0.00110528607567721,0.0038312928270069,-0.00861462001661073,0.00640404786525631,0.772977901927774
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23432.Average Diameter for LDL Particles,40065,-0.00102038317385345,0.00363509646759577,-0.00814517225034114,0.00610440590263425,0.778943403663773
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23433.Average Diameter for HDL Particles,40065,-0.00168738753036181,0.00411177237118599,-0.00974646137788634,0.00637168631716272,0.681535590877851
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23434.Phosphoglycerides,40055,-0.00738347619080962,0.00378383070474346,-0.0147997843721068,3.28319904875675e-05,0.0510442973274645
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,40055,0.00368429123387322,0.00393156664341122,-0.00402157938721278,0.0113901618549592,0.34872532450631
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23436.Total Cholines,40055,-0.007709239134284,0.00379134698856282,-0.0151402792318671,-0.000278199036700873,0.0420386753510204
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23437.Phosphatidylcholines,40055,-0.00718771140411345,0.00381993322372201,-0.0146747805226086,0.000299357714381681,0.0599126186483829
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23438.Sphingomyelins,40055,-0.00664398363339656,0.00371756851478043,-0.0139304179223662,0.000642450655573075,0.0739354282692577
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23439.Apolipoprotein B,40065,-0.00341754816153139,0.00343203354701149,-0.0101443339136739,0.00330923759061114,0.319379525673992
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23440.Apolipoprotein A1,40065,-0.00972282025030035,0.00390762275100707,-0.0173817608422742,-0.0020638796583265,0.0128551812557007
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,40065,0.00184692407444405,0.00351199489009309,-0.00503658591013839,0.0087304340590265,0.598975150521035
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23442.Total Fatty Acids,40055,-0.00440559176173498,0.0036689274752151,-0.0115966896131566,0.00278550608968661,0.229860938321386
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23443.Degree of Unsaturation,40055,-0.0110221669852994,0.00369492158623226,-0.0182642132943147,-0.00378012067628422,0.00286017649822036
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23444.Omega-3 Fatty Acids,40055,-0.00799006480912329,0.00366977658000559,-0.0151828269059342,-0.000797302712312332,0.0294824855054538
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23445.Omega-6 Fatty Acids,40055,-0.00829046698049592,0.00361837795060334,-0.0153824877636785,-0.00119844619731337,0.0219702755723909
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,40055,-0.00925227680628268,0.00366781434263286,-0.0164411929178431,-0.00206336069472228,0.0116646181607654
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23447.Monounsaturated Fatty Acids,40055,-0.000798988028707853,0.00374971439309736,-0.00814842823917868,0.00655045218176297,0.831268795064519
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23448.Saturated Fatty Acids,40055,-0.00242902169859298,0.00367048082754875,-0.00962316412058854,0.00476512072340257,0.508131347446973
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23449.Linoleic Acid,40055,-0.00644476347274549,0.00354006045258651,-0.0133832819598151,0.000493755014324067,0.0687068172450162
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23450.Docosahexaenoic Acid,40055,-0.00817970918490042,0.00367038233910413,-0.0153736585695445,-0.000985759800256319,0.0258628205811561
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,40055,-0.00686767839599569,0.00361304190061309,-0.0139492405211974,0.00021388372920597,0.0573543585616388
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,40055,-0.00479709659672065,0.00392048538215072,-0.012481247945736,0.00288705475229476,0.221130601320415
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,40055,-0.00784783263382887,0.00386124327147433,-0.0154158694459186,-0.000279795821739186,0.0421311230106628
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,40055,0.00657602099922449,0.00392344725792296,-0.00111393562630451,0.0142659776247535,0.0937508305339113
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,40055,0.0053204238408262,0.00355912074872951,-0.00165545282668363,0.012296300508336,0.13497735189614
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,40055,-0.00400040903588527,0.00375918717574374,-0.011368415900343,0.00336759782857246,0.28727597705137
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,40055,-0.00583243975849372,0.00361394727153143,-0.0129157764106953,0.00125089689370788,0.106584756963269
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,40055,-0.00746314650348996,0.00392194042867506,-0.0151501497436931,0.000223856736713155,0.0570771475980555
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,40055,0.00525730136444106,0.00358161459332184,-0.00176266323846974,0.0122772659673519,0.142171776936981
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23460.Alanine,40060,-0.00718613506389915,0.00355686035886131,-0.0141575813672673,-0.00021468876053098,0.0433706424718676
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23461.Glutamine,40027,-0.00770249660353071,0.00355286483076612,-0.0146661116718323,-0.00073888153522912,0.0301828371097934
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23462.Glycine,40051,-9.41687019221052e-05,0.00377037583869111,-0.00748410534575668,0.00729576794191247,0.980074609245682
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23463.Histidine,40049,-0.00618482846368282,0.00349885980720545,-0.0130425936858055,0.000672936758439866,0.0771442270050187
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),40058,-0.0044712513869388,0.00370030865718338,-0.0117238563550182,0.00278135358114062,0.226940686901831
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23465.Isoleucine,40062,-0.00192711634948838,0.00360594985260463,-0.00899477806059346,0.0051405453616167,0.593057192395474
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23466.Leucine,40062,-0.00370148400177238,0.00363975298941651,-0.0108353998610287,0.00343243185748398,0.309194991950651
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23467.Valine,40058,-0.00577803940518745,0.00374522672133419,-0.0131186837790025,0.00156260496862756,0.122914681291574
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23468.Phenylalanine,40059,0.00162120485599348,0.00354226153090743,-0.00532162774458508,0.00856403745657203,0.647195040611827
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23469.Tyrosine,40051,-0.0010017254432133,0.00360604641414408,-0.0080695764149357,0.00606612552850909,0.781178472165549
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23470.Glucose,40044,-0.00798858002398602,0.00352469792974515,-0.0148969879662865,-0.00108017208168552,0.0234429564137321
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23471.Lactate,40045,0.00611658924910261,0.00354390393087849,-0.000829462455419237,0.0130626409536244,0.0843854713771411
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23472.Pyruvate,40029,0.00667415286698094,0.00353280416684993,-0.000250143300044932,0.0135984490340068,0.0588925000499471
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23473.Citrate,40063,0.000276997205022398,0.00353760101346327,-0.00665670078136561,0.00721069519141041,0.937590174003959
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23474.3-Hydroxybutyrate,39883,0.00440530274997636,0.00372983211583682,-0.00290516819706381,0.0117157736970165,0.237589487593808
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23475.Acetate,40054,-0.00141543486384365,0.00349543605451098,-0.00826648953068518,0.00543561980299788,0.685531065384319
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23476.Acetoacetate,40064,-0.00338077563156747,0.00358836955410128,-0.010413979957606,0.00365242869447103,0.34613774845706
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23477.Acetone,40064,-0.000832653302745182,0.00354452775876002,-0.00777992770991482,0.00611462110442445,0.814281198029623
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23478.Creatinine,39815,0.0107397569429531,0.00413523420473035,0.0026346979016816,0.0188448159842246,0.00941348925680392
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23479.Albumin,40062,-0.00976457138123985,0.003552682680709,-0.0167278294354295,-0.00280131332705022,0.00599662571339324
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23480.Glycoprotein Acetyls,40065,0.00178587608662552,0.0037852710124095,-0.0056332550976971,0.00920500727094813,0.637081806668562
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,40065,0.00130964644296831,0.0037894333607948,-0.00611764294418949,0.00873693583012611,0.729646408736136
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,40065,0.00178306015962206,0.003740711027208,-0.00554873345370562,0.00911485377294975,0.633611386480663
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,40065,0.00127491115119939,0.00380014424987861,-0.00617337157856269,0.00872319388096147,0.737261810608672
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,40065,0.00057088676138474,0.00375627592789837,-0.00679141405729607,0.00793318758006555,0.879203861982765
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,40065,0.000979571983633443,0.00370891234253058,-0.00628989620772649,0.00824904017499337,0.79169784962618
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,40065,0.000408930343941634,0.00379242890117769,-0.00702423030236663,0.0078420909902499,0.914134054483173
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,40065,0.00170052879458043,0.00371012663475437,-0.00557131940953813,0.008972376998699,0.646711669809704
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,40065,1.74684585923123e-05,0.00377502972216078,-0.00738158979684281,0.00741652671402743,0.996307991149755
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,40065,0.000450586141205368,0.00375630589273904,-0.00691177340856314,0.00781294569097388,0.904521335066965
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,40065,0.000195305546679897,0.00374753731449808,-0.00714986758973635,0.00754047868309614,0.95843745727023
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,40065,-0.000855919884510152,0.00365998664282891,-0.00802949370445481,0.00631765393543451,0.815099045155901
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,40065,-0.00159069639299799,0.00360024585247438,-0.00864717826384777,0.00546578547785179,0.658621063004278
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,40065,-0.00020633440416939,0.00372047705471724,-0.00749846943141518,0.0070858006230764,0.955773712038115
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,40065,0.00108446765413375,0.00377896399783152,-0.00632230178161603,0.00849123708988352,0.774137041181927
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23495.Concentration of Large VLDL Particles,40065,-0.000316933391679857,0.00372919934251949,-0.00762616410301806,0.00699229731965835,0.932273306344362
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23496.Total Lipids in Large VLDL,40065,-0.000362906252989481,0.00370769207644517,-0.007629982722822,0.00690417021684304,0.922029952906868
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23497.Phospholipids in Large VLDL,40065,-0.000254386174855789,0.00372601798354109,-0.00755738142259633,0.00704860907288475,0.945569626083978
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23498.Cholesterol in Large VLDL,40065,-0.000983579872091308,0.00365375397281648,-0.00814493765881161,0.00617777791462899,0.787783142028469
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,40065,-0.000957771672970619,0.00358965404520667,-0.0079934936015757,0.00607795025563446,0.789617066672465
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,40065,-0.00102095924807056,0.00371954119851157,-0.00831125999715324,0.00626934150101212,0.783716942165012
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23501.Triglycerides in Large VLDL,40065,-0.000423367456376904,0.00369974441523849,-0.00767486651024434,0.00682813159749053,0.908897825039114
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,40065,-0.0026870466506883,0.00350140573815613,-0.00954980189747433,0.00417570859609772,0.442848871450108
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23503.Total Lipids in Medium VLDL,40065,-0.00227245739915463,0.00353890571923226,-0.00920871260884986,0.0046637978105406,0.520798673768126
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23504.Phospholipids in Medium VLDL,40065,-0.0024740889695001,0.00348718618050079,-0.00930897388328165,0.00436079594428144,0.478041853463423
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23505.Cholesterol in Medium VLDL,40065,-0.00348063818440885,0.00342730068289861,-0.0101981475228901,0.00323687115407241,0.30986035270864
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,40065,-0.00433827474637128,0.00344038664984331,-0.0110814325800642,0.00240488308732161,0.207341439420251
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,40065,-0.00251126790235865,0.00346302120708739,-0.00929878946824993,0.00427625366353262,0.4683653350147
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23508.Triglycerides in Medium VLDL,40065,-0.000888428919348641,0.00366988950725011,-0.00808141235355885,0.00630455451486157,0.808718082334983
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23509.Concentration of Small VLDL Particles,40065,-0.000561355113914645,0.00361146919944125,-0.00763983474481949,0.0065171245169902,0.876479882606517
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23510.Total Lipids in Small VLDL,40065,-0.000950580827839278,0.00360079469348071,-0.00800813842706147,0.00610697677138292,0.79179112255799
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23511.Phospholipids in Small VLDL,40065,-0.00199987323705245,0.00351933330078361,-0.00889776650658834,0.00489802003248343,0.569874629677375
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23512.Cholesterol in Small VLDL,40065,-0.00145185896980869,0.00348379573320796,-0.00828009860689629,0.00537638066727891,0.676872215484832
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,40065,-0.000810335373497395,0.0034995386037924,-0.0076694310369305,0.00604876028993571,0.816888084383313
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,40065,-0.00250508434115456,0.0034608926624656,-0.00928843395958713,0.00427826527727801,0.469188096069075
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23515.Triglycerides in Small VLDL,40065,0.000329924809495424,0.00373468072002866,-0.00699004940176074,0.00764989902075159,0.929607412200688
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,40065,0.000963857841927362,0.00352085764445575,-0.00593702314120591,0.00786473882506064,0.78427691738793
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,40065,0.000892746402804512,0.00355266645940569,-0.00607047985763064,0.00785597266323966,0.801595341498357
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,40065,0.00189971299635413,0.00355282136721561,-0.00506381688338848,0.00886324287609673,0.592864478495998
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,40065,-0.000519021530552406,0.00351111795390936,-0.00740081272021475,0.00636276965910994,0.882485751542061
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,40065,-0.00118802008967149,0.00351747228084837,-0.0080822657601343,0.00570622558079131,0.735559436072102
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,40065,0.000955400768994317,0.00352517995552389,-0.00595395194383251,0.00786475348182115,0.786379378039083
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,40065,0.00245633569007535,0.00373410372275382,-0.00486250760652214,0.00977517898667283,0.510673309465374
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23523.Concentration of IDL Particles,40065,-0.00316379307054494,0.00342359429110186,-0.00987403788110458,0.00354645174001471,0.355447224441162
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23524.Total Lipids in IDL,40065,-0.00512623669617738,0.00352866297047146,-0.0120424161183014,0.00178994272594668,0.146324279647478
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23525.Phospholipids in IDL,40065,-0.00382807127934552,0.00353182958977124,-0.0107504572752972,0.00309431471660611,0.2784430727947
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23526.Cholesterol in IDL,40065,-0.00610648962818421,0.00352906789979113,-0.0130234627117748,0.000810483455406406,0.0835978109952848
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23527.Cholesteryl Esters in IDL,40065,-0.00646732582714191,0.003533988558467,-0.0133939434017372,0.000459291747453403,0.0672719427547543
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23528.Free Cholesterol in IDL,40065,-0.004834151525554,0.00351181190050376,-0.0117173028505414,0.00204899979943337,0.168682688541103
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23529.Triglycerides in IDL,40065,0.00262510618506951,0.00374178940156289,-0.00470880104199376,0.00995901341213279,0.482965886215724
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23530.Concentration of Large LDL Particles,40065,-0.00365244337375633,0.0034309779897764,-0.0103771602337181,0.00307227348620542,0.287103820944495
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23531.Total Lipids in Large LDL,40065,-0.00638187574929835,0.00348802317276612,-0.0132184011679199,0.000454649669323255,0.0673290570588665
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23532.Phospholipids in Large LDL,40065,-0.00654142588356621,0.00346461231656991,-0.0133320660240432,0.000249214256910828,0.0590433410829132
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23533.Cholesterol in Large LDL,40065,-0.00672735671096653,0.00349417686974628,-0.0135759433756692,0.000121229953736183,0.0542172512948178
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,40065,-0.00647494184285647,0.00349295205005399,-0.0133211278609623,0.00037124417524935,0.0638068420102932
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23535.Free Cholesterol in Large LDL,40065,-0.0071907455870894,0.00350167614587839,-0.014054030833011,-0.000327460341167753,0.0400464962183754
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23536.Triglycerides in Large LDL,40065,0.0012496031280117,0.003749820894889,-0.00610004582597075,0.00859925208199415,0.738956973915263
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23537.Concentration of Medium LDL Particles,40065,-0.00466413530200575,0.00345285765633899,-0.0114317363084302,0.00210346570441866,0.17678621445818
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23538.Total Lipids in Medium LDL,40065,-0.00607682970552651,0.00347422014350197,-0.0128863011867904,0.000732641775737358,0.080298410380367
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23539.Phospholipids in Medium LDL,40065,-0.00641110156664911,0.00346470725427076,-0.0132019277850198,0.000379724651721588,0.0642827307401392
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23540.Cholesterol in Medium LDL,40065,-0.00623887773713685,0.00346639746699001,-0.0130330167724373,0.000555261298163568,0.071917407295747
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,40065,-0.00580842125543085,0.00348450716858959,-0.0126380553058665,0.00102121279500475,0.0955576033973372
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,40065,-0.00705319400252559,0.0034555994820737,-0.01382616898739,-0.000280219017661149,0.0412658535291754
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23543.Triglycerides in Medium LDL,40065,0.000385644800814861,0.00376628893451851,-0.00699628151084141,0.00776757111247113,0.918445958504229
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23544.Concentration of Small LDL Particles,40065,-0.00264609423171296,0.00343009793848518,-0.00936908619114391,0.004076897727718,0.440466485929891
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23545.Total Lipids in Small LDL,40065,-0.00486835869546895,0.00343888365840635,-0.0116085706659454,0.0018718532750075,0.156897874905062
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23546.Phospholipids in Small LDL,40065,-0.00368238859659245,0.00341378163718142,-0.010373400605468,0.00300862341228315,0.280752950228479
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23547.Cholesterol in Small LDL,40065,-0.00567476127322543,0.00343638475030864,-0.0124100753838304,0.0010605528373795,0.0986908262414933
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,40065,-0.00534145552119273,0.00345786792471564,-0.0121188766536354,0.00143596561124992,0.122441868806148
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23549.Free Cholesterol in Small LDL,40065,-0.00595698803058439,0.00342796431746743,-0.0126757980928205,0.000761822031651763,0.0822809791492896
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23550.Triglycerides in Small LDL,40065,0.000663217709885789,0.00377550058851734,-0.00673676344360819,0.00806319886337977,0.860561570949437
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,40065,-0.00096320652104945,0.003930877220653,-0.00866772587352932,0.00674131283143042,0.806433164189208
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23552.Total Lipids in Very Large HDL,40065,0.000348397880615037,0.0039484794446601,-0.00739062183091876,0.00808741759214884,0.929690760837716
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23553.Phospholipids in Very Large HDL,40065,0.00135004283856082,0.00396918228957023,-0.00642955444899683,0.00912964012611847,0.733764278797465
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23554.Cholesterol in Very Large HDL,40065,-0.00104528938551715,0.00391255910569594,-0.00871390523268119,0.00662332646164689,0.789349053870385
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,40065,-0.00178152377238233,0.00395807395217437,-0.00953934871864411,0.00597630117387944,0.652648279808592
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,40065,0.00132465771512769,0.00372894320684602,-0.0059840709702905,0.00863338640054589,0.72241911715018
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23557.Triglycerides in Very Large HDL,40065,0.00106511101139654,0.00367945460915478,-0.00614662002254683,0.00827684204533992,0.772223244082853
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23558.Concentration of Large HDL Particles,40065,-0.00452036297263851,0.00413774453213783,-0.0126303422556287,0.00358961631035164,0.274650651242316
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23559.Total Lipids in Large HDL,40065,-0.0043432626777052,0.00414216453108688,-0.0124619051586355,0.00377537980322508,0.29440902714133
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23560.Phospholipids in Large HDL,40065,-0.00425168659526089,0.00413672635556708,-0.0123596702521724,0.00385629706165058,0.304071418839405
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23561.Cholesterol in Large HDL,40065,-0.00430128363125199,0.00410372613005335,-0.0123445868461566,0.00374201958365258,0.294596948267484
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,40065,-0.00464620269333818,0.00409653958119617,-0.0126754202724827,0.00338301488580632,0.256745142542239
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23563.Free Cholesterol in Large HDL,40065,-0.00304204310012512,0.00410440239403732,-0.0110866717924383,0.00500258559218803,0.458608865041576
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23564.Triglycerides in Large HDL,40065,-0.000653204507684775,0.00378549503058653,-0.00807277476763438,0.00676636575226483,0.863004767855317
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23565.Concentration of Medium HDL Particles,40065,-0.00939123628641747,0.0038705915575634,-0.0169775957392417,-0.00180487683359319,0.0152695939480609
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23566.Total Lipids in Medium HDL,40065,-0.00896669582602498,0.0038349794861636,-0.0164832556189056,-0.00145013603314432,0.0193983345744525
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23567.Phospholipids in Medium HDL,40065,-0.00813223302875834,0.00381023920986751,-0.0156003018800987,-0.000664164177418014,0.0328396905926487
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23568.Cholesterol in Medium HDL,40065,-0.0099409723219011,0.00386464395050686,-0.0175156744648945,-0.00236627017890767,0.0101160711184505
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,40065,-0.01001464584262,0.00384271990154574,-0.0175463768496497,-0.00248291483559037,0.00916953206037511
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,40065,-0.00900336260434067,0.00393473548275104,-0.0167154441505327,-0.00129128105814864,0.0221464468679062
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23571.Triglycerides in Medium HDL,40065,-0.00134493226093235,0.00366616972089265,-0.00853062491388194,0.00584076039201724,0.713738476829679
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23572.Concentration of Small HDL Particles,40065,-0.010445891936622,0.0035349877080397,-0.0173744678443798,-0.00351731602886421,0.00313338738221582
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23573.Total Lipids in Small HDL,40065,-0.00941907431447878,0.00356190952821393,-0.0164004169897781,-0.00243773163917948,0.00819561195967764
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23574.Phospholipids in Small HDL,40065,-0.0090466178610605,0.00358354116962318,-0.0160703585535219,-0.00202287716859907,0.0116007070081957
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23575.Cholesterol in Small HDL,40065,-0.0105661632275847,0.00353424076755974,-0.0174932751320018,-0.00363905132316757,0.00279917075466257
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,40065,-0.010707283426308,0.00350774540262062,-0.0175824644154444,-0.0038321024371716,0.00227515394668363
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23577.Free Cholesterol in Small HDL,40065,-0.00903104258284073,0.00363848545807318,-0.0161624740806642,-0.00189961108501729,0.0130764725051744
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23578.Triglycerides in Small HDL,40065,-0.000148569399347595,0.00374057420582651,-0.00748009484276756,0.00718295604407237,0.968318409096987
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39651,-0.00340922723822383,0.00360255356931421,-0.0104702322340797,0.00365177775763202,0.343998947357083
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39651,-0.00210738443254525,0.00370640216895227,-0.00937193268369169,0.00515716381860119,0.569653724199367
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39651,0.000424557559190243,0.00366088280669487,-0.00675077274193171,0.00759988786031219,0.907677466635068
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39651,-0.00426225193709892,0.00372824473802809,-0.011569611623634,0.00304510774943613,0.252968089526176
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39651,0.00210623567656354,0.00367703432221296,-0.00510075159497385,0.00931322294810094,0.566786833289179
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,39972,0.00105371557203663,0.00357746462470643,-0.00595811509238798,0.00806554623646124,0.768349022905346
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,39972,-0.00444619927847733,0.00375196755205619,-0.0118000556805075,0.00290765712355281,0.236031169061461
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,39972,-0.00449454972590979,0.00376081232179972,-0.0118657418766372,0.00287664242481765,0.232073954560153
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,39972,-0.00321929031696811,0.00369704462400714,-0.0104654977800221,0.00402691714608589,0.383896960957711
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,39972,0.00375765492464901,0.00368560021625,-0.00346612149920098,0.010981431348499,0.307964655286124
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,40064,0.00512563373612032,0.00367175364341148,-0.00207100340496618,0.0123222708772068,0.162754023486641
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,40064,-0.00323347659051354,0.00356294527442659,-0.0102168493283896,0.00374989614736257,0.364147175614554
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,40064,-0.00264388682493489,0.00365998578304796,-0.00981745895970889,0.00452968530983911,0.470078721595343
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,40064,-0.00230854115753807,0.00351237074297013,-0.00919278781375953,0.00457570549868338,0.511027601208534
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,40064,0.000382640611810151,0.00350292809143055,-0.00648309844739373,0.00724837967101403,0.913018510339753
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,40065,-0.00135450448587255,0.00356006162689163,-0.00833222527458014,0.00562321630283503,0.703602361270742
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,40065,-0.00239011439857408,0.00369732545904781,-0.00963687229830779,0.00485664350115963,0.518005405252177
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,40065,-0.00294394017008739,0.0037352341692005,-0.0102649991417204,0.00437711880154559,0.430623751908176
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,40065,-0.00122196663572384,0.00360568632709784,-0.00828911183683561,0.00584517856538792,0.734691706334836
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,40065,0.00213240590124426,0.0036623495837487,-0.00504579928290319,0.0093106110853917,0.560409848620693
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,40065,-0.00358851638604077,0.00368939286561986,-0.0108197264026557,0.00364269363057416,0.330745095458556
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,40065,-0.00178333937604726,0.00359690412059662,-0.00883327145241664,0.00526659270032212,0.620046663198673
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,40065,-8.66252679914938e-05,0.00353154341262879,-0.00700845035674392,0.00683519982076093,0.980431093277049
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,40065,-0.00361134215801242,0.00370331870787415,-0.0108698468254457,0.00364716250942091,0.329500738819991
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,40065,0.00236535789797096,0.00362763056283051,-0.00474479800517683,0.00947551380111876,0.514389569008356
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,40065,0.00856429451094581,0.00360759114922531,0.0014934158584642,0.0156351731634274,0.0176154955244634
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,40065,-0.00397137747426187,0.00373610358681353,-0.0112941405044164,0.00335138555589265,0.28781777881726
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,40065,-0.00441324404700071,0.00376654772431646,-0.011795677586661,0.00296918949265955,0.241345326002819
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,40065,0.000125806280501236,0.00354243314224599,-0.00681736267830091,0.00706897523930338,0.971670465326439
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,40065,0.00265179844459032,0.00372004238636903,-0.00463948463269298,0.00994308152187363,0.47595950008374
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,40065,0.00797921000460873,0.00342044688323566,0.00127513411346683,0.0146832858957506,0.0196769244451844
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,40065,-0.00780783762493846,0.00361570199258441,-0.0148946135304039,-0.000721061719473007,0.0308390026963146
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,40065,-0.00962991814770292,0.00362291088635542,-0.0167308234849595,-0.00252901281044631,0.00787066730673471
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,40065,-0.000716420980653336,0.0034583704131809,-0.0074948269904879,0.00606198502918123,0.835892179945827
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,40065,0.00725638534588539,0.00372185562317685,-3.84516755412324e-05,0.014551222367312,0.0512412966890045
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,40065,-0.000464659960250551,0.00345806899284422,-0.00724247518622522,0.00631315526572412,0.89311266661446
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,40065,-0.00836018912850805,0.00373705901871787,-0.0156848248051951,-0.00103555345182104,0.0252997410131457
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,40065,-0.00446265514633518,0.00346906793018485,-0.0112620282894975,0.00233671799682712,0.19832625209193
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,40065,-0.00542268565769998,0.00373227550282714,-0.0127379456432412,0.00189257432784121,0.146275728338548
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,40065,0.0085047698095262,0.00372684959197353,0.00120014460925807,0.0158093950097943,0.022507006123913
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,40065,-0.00223118623832594,0.0035231642013128,-0.00913658807289904,0.00467421559624715,0.526557311453822
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,40065,-0.00539594934395439,0.00344649486535845,-0.0121510792800569,0.00135918059214817,0.11746344565475
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,40065,-0.000125791054675227,0.00356017816039375,-0.00710374024904697,0.00685215813969652,0.971815019593061
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,40065,-0.00395580912711887,0.00380993767280748,-0.0114232869658215,0.00351166871158379,0.299159506756567
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,40065,0.0076466956519676,0.00366172539490627,0.000469713877951312,0.0148236774259839,0.0367960979416025
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,40065,0.00565405972192129,0.00349496035429901,-0.00119606257250477,0.0125041820163474,0.105740093598468
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,40065,-0.0100107444366655,0.00351247488237124,-0.0168951952061131,-0.00312629366721785,0.00437939686807511
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,40065,-0.00462422318923828,0.00349869660544581,-0.0114816685359121,0.0022332221574355,0.186296273012937
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,40065,-0.00413322135815481,0.00372986868823603,-0.0114437639870974,0.0031773212707878,0.267825333954222
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,40065,0.00502618277914171,0.00372961671215639,-0.00228386597668482,0.0123362315349682,0.17780210036783
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,40057,0.00476358794648338,0.0038762905960687,-0.00283394162181128,0.012361117514778,0.219134525394532
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,40057,-0.00672004859154113,0.00366859880361041,-0.0139105022466175,0.00047040506353528,0.0670122745561842
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,40057,-0.00958251457790889,0.00357236055749884,-0.0165843412706066,-0.00258068788521117,0.00732057001949757
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,40057,0.000778598907995704,0.00408375638064109,-0.00722556359806083,0.00878276141405224,0.84879747655721
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,40057,-0.000870181257947713,0.00387954376504057,-0.00847408703742723,0.0067337245215318,0.822528176538191
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,40065,0.00173773716254539,0.00378900468016479,-0.0056887120105776,0.00916418633566837,0.64651172198313
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,40065,-0.00303861511526818,0.00391783170872258,-0.0107175652643644,0.00464033503382807,0.438010386949247
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,40065,-0.00452876780911968,0.00394072647329497,-0.0122525916967778,0.00319505607853847,0.250489917961368
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,40065,0.00167657185254365,0.00370577956779236,-0.00558675610032937,0.00893989980541668,0.650974874348046
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,40065,0.00302213396997805,0.00388018556838203,-0.00458302974405073,0.0106272976840068,0.436077223231705
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,40065,0.0090984656435112,0.00384841401071511,0.00155557418250959,0.0166413571045128,0.0180859589697228
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,40065,-0.00672489874903672,0.00381026124712109,-0.0141930107933941,0.000743213295320619,0.0776012062010611
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,40065,-0.00587324719860552,0.00377656039644969,-0.0132753055756469,0.00152881117843588,0.119931307330834
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,40065,-0.00717467344754188,0.00402515168027998,-0.0150639707408906,0.00071462384580688,0.0747020843605701
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,40065,0.00483602687237942,0.00375392725608746,-0.002521670549552,0.0121937242943108,0.197683581511252
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,40065,0.00222908099118997,0.0036498765922298,-0.00492467712958043,0.00938283911196037,0.541392586582573
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,40065,-0.00484282758314874,0.00365101538865736,-0.0119988177449172,0.00231316257861968,0.18472415239682
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,40065,-0.00563741783320411,0.00368394036333714,-0.0128579409453449,0.00158310527893668,0.125979382675306
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,40065,0.00105148115108696,0.0036685318811955,-0.00613884133605621,0.00824180363823013,0.774407395179159
FOS,Proto-oncogene c-Fos,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,40065,0.00525031365375477,0.00379000310421156,-0.00217809243049988,0.0126787197380094,0.16598737404491
FOS,Proto-oncogene c-Fos,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,48336,0.000301281712254057,0.00301241171122166,-0.0056030452417404,0.00620560866624852,0.920334688420148
FOS,Proto-oncogene c-Fos,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,48336,0.000942809795014357,0.0029400151463862,-0.00481961989190259,0.00670523948193131,0.74845492663128
FOS,Proto-oncogene c-Fos,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,47033,0.00238907912380621,0.00280091583382073,-0.00310071591048243,0.00787887415809485,0.393690967705404
FOS,Proto-oncogene c-Fos,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,47033,-0.0021351125490217,0.00308684982587577,-0.00818533820773821,0.00391511310969481,0.489147257997783
FOS,Proto-oncogene c-Fos,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,47033,0.00133403505258898,0.002993749014632,-0.00453371301608975,0.0072017831212677,0.655886672932017
FOS,Proto-oncogene c-Fos,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,47033,0.00224762451600453,0.00274914430801022,-0.00314069832769551,0.00763594735970457,0.413612310593776
FOS,Proto-oncogene c-Fos,Working and living environment,X24009.Traffic intensity on the nearest road,48336,-0.129507835612775,0.0823000914778983,-0.290816014909455,0.0318003436839061,0.11559532373487
FOS,Proto-oncogene c-Fos,Working and living environment,X24010.Inverse distance to the nearest road,48336,0.00156937831084859,0.0026475245397225,-0.00361976978700751,0.00675852640870468,0.553340777977401
FOS,Proto-oncogene c-Fos,Working and living environment,X24011.Traffic intensity on the nearest major road,48336,0.00685020304386398,0.00260213772643348,0.00175001310005436,0.0119503929876736,0.00848198233451901
FOS,Proto-oncogene c-Fos,Working and living environment,X24012.Inverse distance to the nearest major road,48336,-0.00284164400928578,0.00267066185010909,-0.00807614123549961,0.00239285321692804,0.287331977809528
FOS,Proto-oncogene c-Fos,Working and living environment,X24013.Total traffic load on major roads,48336,-0.103114644515923,0.0579170093035462,-0.216631982750874,0.0104026937190272,0.0750286350360682
FOS,Proto-oncogene c-Fos,Working and living environment,X24015.Sum of road length of major roads within 100m,48336,-0.104614487259477,0.0563592231599953,-0.215078564653067,0.00584959013411408,0.0634391552977806
FOS,Proto-oncogene c-Fos,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,48336,0.00161489162211717,0.00299969993830269,-0.0042645202569561,0.00749430350119043,0.590340970847304
FOS,Proto-oncogene c-Fos,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,48336,0.00130489021788074,0.00299364607653814,-0.00456265609213402,0.0071724365278955,0.662923921201422
FOS,Proto-oncogene c-Fos,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,48336,0.00233696371925683,0.00296018915008799,-0.00346500701491563,0.0081389344534293,0.429850453166544
FOS,Proto-oncogene c-Fos,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,48288,0.00640201516153728,0.00294855078582878,0.000622855621312883,0.0121811747017617,0.0299252128208157
FOS,Proto-oncogene c-Fos,Working and living environment,X24020.Average daytime sound level of noise pollution,48336,-0.000659535170904914,0.00265286528953539,-0.00585915113839428,0.00454008079658445,0.803663293263889
FOS,Proto-oncogene c-Fos,Working and living environment,X24021.Average evening sound level of noise pollution,48336,-0.000656494881964072,0.0026537062691142,-0.00585775916942791,0.00454476940549977,0.804610673120442
FOS,Proto-oncogene c-Fos,Working and living environment,X24022.Average night-time sound level of noise pollution,48336,-0.000664073345512912,0.00265274488198559,-0.00586345331420467,0.00453530662317885,0.802331428653193
FOS,Proto-oncogene c-Fos,Working and living environment,X24023.Average 16-hour sound level of noise pollution,48336,-0.000663853690290521,0.00265323710972525,-0.005864198425352,0.00453649104477096,0.802431358376484
FOS,Proto-oncogene c-Fos,Working and living environment,X24024.Average 24-hour sound level of noise pollution,48336,-0.000687802819517383,0.00265327652525825,-0.00588822480902355,0.00451261916998879,0.795462333368837
FOS,Proto-oncogene c-Fos,Health and medical history,X2405.Number of children fathered,38258,-0.108643916653621,0.0658447619394071,-0.237699650054859,0.0204118167476166,0.0989774004238356
FOS,Proto-oncogene c-Fos,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",46271,8.44593134856877e-05,0.00307971309738056,-0.00595177835738021,0.00612069698435159,0.978121549963302
FOS,Proto-oncogene c-Fos,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",46271,0.000260781243077673,0.00276709916870211,-0.00516273312757846,0.00568429561373381,0.924916798140114
FOS,Proto-oncogene c-Fos,Working and living environment,"X24502.Water percentage, buffer 1000m",46271,0.00495709366180012,0.00280139690531581,-0.00053364427261886,0.0104478315962191,0.076827014195676
FOS,Proto-oncogene c-Fos,Working and living environment,"X24503.Greenspace percentage, buffer 300m",46271,0.000418765642458259,0.00287923767551813,-0.00522454020155728,0.0060620714864738,0.884362647346182
FOS,Proto-oncogene c-Fos,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",46271,-0.000498882723127868,0.00277944780079469,-0.00594660041268547,0.00494883496642973,0.857555200621816
FOS,Proto-oncogene c-Fos,Working and living environment,"X24505.Water percentage, buffer 300m",46271,0.00721799278303138,0.00283553564449258,0.00166034291982592,0.0127756426462368,0.010919340940651
FOS,Proto-oncogene c-Fos,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",48460,0.000377288222974201,0.00294825898652222,-0.00540129939060936,0.00615587583655776,0.898174178700559
FOS,Proto-oncogene c-Fos,Working and living environment,"X24507.Natural environment percentage, buffer 300m",48460,-0.00141358666159262,0.00276789107489327,-0.00683865316838342,0.00401147984519818,0.609560745371156
FOS,Proto-oncogene c-Fos,Working and living environment,X24508.Distance (Euclidean) to coast,48460,-0.000675595115079939,0.00260524871158528,-0.00578188258978709,0.00443069235962721,0.795390522031387
FOS,Proto-oncogene c-Fos,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,34531,-0.107259069477803,0.0739102477332289,-0.252123155034931,0.0376050160793261,0.146780999783681
FOS,Proto-oncogene c-Fos,Health and medical history,X2704.Years since last cervical smear test,37013,0.0749200152266059,0.0652188084043168,-0.052908849245855,0.202748879699067,0.250694797261485
FOS,Proto-oncogene c-Fos,Health and medical history,X2714.Age when periods started (menarche),39040,0.0396658722667541,0.0518708005822299,-0.0620008968744166,0.141332641407925,0.444465420705319
FOS,Proto-oncogene c-Fos,Health and medical history,X2734.Number of live births,39344,0.0553139695065696,0.0501487895273768,-0.042977657967089,0.153605596980228,0.270054592485287
FOS,Proto-oncogene c-Fos,Health and medical history,X2744.Birth weight of first child,37796,-0.0594133562644787,0.053631491100426,-0.164531078821314,0.0457043662923563,0.267976059003094
FOS,Proto-oncogene c-Fos,Health and medical history,X2754.Age at first live birth,36761,-0.00895535948583636,0.00483027940317302,-0.0184227071160555,0.000511988144382754,0.0637774047650655
FOS,Proto-oncogene c-Fos,Health and medical history,X2764.Age at last live birth,36737,-0.00101689942208296,0.00443929625629492,-0.009717920084421,0.00768412124025507,0.818822500276344
FOS,Proto-oncogene c-Fos,Health and medical history,X2794.Age started oral contraceptive pill,35834,-0.00347258122429857,0.00684779078370637,-0.0168942511603631,0.00994908871176591,0.612094677556866
FOS,Proto-oncogene c-Fos,Health and medical history,X2804.Age when last used oral contraceptive pill,35189,-0.000301558451927201,0.00519932039312899,-0.01049222642246,0.00988910951860563,0.953750887671965
FOS,Proto-oncogene c-Fos,Lifestyle factors,X2867.Age started smoking in former smokers,35095,-0.0119293012106255,0.00480133482868441,-0.0213399174748469,-0.00251868494640406,0.0129979435283055
FOS,Proto-oncogene c-Fos,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",34982,0.031337593876495,0.0872740393798375,-0.139719523307987,0.202394711060976,0.71955492956249
FOS,Proto-oncogene c-Fos,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,34980,0.0458287066835243,0.0951830183932407,-0.140730009367227,0.232387422734276,0.630193702899046
FOS,Proto-oncogene c-Fos,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,34992,-0.020897422521263,0.099277651245387,-0.215481618962222,0.173686773919695,0.833288962676861
FOS,Proto-oncogene c-Fos,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",34967,0.0217190144671373,0.0968245368403025,-0.168057077739855,0.21149510667413,0.822521604746389
FOS,Proto-oncogene c-Fos,Mental health,X28739.Difficulty with standing for long periods,34993,0.0256176806706881,0.0740133054290847,-0.119448397970318,0.170683759311694,0.729263112656587
FOS,Proto-oncogene c-Fos,Mental health,X28740.Difficulty with taking care of household responsibilities,35015,0.0423633214270089,0.0827012439819143,-0.119731116777543,0.204457759631561,0.608498804702301
FOS,Proto-oncogene c-Fos,Mental health,X28741.Difficulty learning a new task,34959,0.0953338935676296,0.0949436764724683,-0.0907557123184084,0.281423499453668,0.315367767702558
FOS,Proto-oncogene c-Fos,Mental health,X28742.Difficulty with joining in community activities,34743,-0.000725288047708113,0.1015632331115,-0.199789224946248,0.198338648850832,0.994302415226718
FOS,Proto-oncogene c-Fos,Mental health,X28743.Difficulty with being emotionally affected by health problems,34985,-0.0188889048986913,0.0851830741904779,-0.185847730312028,0.148069920514645,0.82452036514132
FOS,Proto-oncogene c-Fos,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,35016,0.0324462136052913,0.130113800746831,-0.222576835858497,0.287469263069079,0.803084964965506
FOS,Proto-oncogene c-Fos,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,34711,-0.0775143248681469,0.0765631895078792,-0.22757817630359,0.0725495265672963,0.311380301423753
FOS,Proto-oncogene c-Fos,Lifestyle factors,X2897.Age stopped smoking,35092,0.00576291699746124,0.0045210211662908,-0.00309828448846872,0.0146241184833912,0.202467899940137
FOS,Proto-oncogene c-Fos,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,34405,0.015620057284888,0.0113067504400543,-0.00654117357761855,0.0377812881473945,0.167190442273806
FOS,Proto-oncogene c-Fos,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,34405,-0.00463979641471907,0.0126253544229362,-0.0293854910836739,0.0201058982542358,0.713262276405749
FOS,Proto-oncogene c-Fos,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,34405,-0.0366502475318231,0.0432212146409467,-0.121363828228079,0.0480633331644324,0.396494215735746
FOS,Proto-oncogene c-Fos,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,34405,-0.0654000376213482,0.0504829238722569,-0.164346568410972,0.0335464931682753,0.195209216374136
FOS,Proto-oncogene c-Fos,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,34405,0.0200785710349725,0.0599396779180406,-0.0974031976843871,0.137560339754332,0.73765393652749
FOS,Proto-oncogene c-Fos,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,34405,-0.0647042875448163,0.0494752107436625,-0.161675700602395,0.0322671255127621,0.190994683404644
FOS,Proto-oncogene c-Fos,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,34405,-0.0313202985063396,0.0206708284242122,-0.0718351222177955,0.00919452520511624,0.129784138504296
FOS,Proto-oncogene c-Fos,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,34405,-0.0484195650297809,0.0357644586787706,-0.118517904040171,0.0216787739806095,0.175844265123567
FOS,Proto-oncogene c-Fos,Mental health,X29002.Recent lack of interest or pleasure in doing things,34376,-0.106899037184671,0.0993834848786908,-0.301690667546905,0.0878925931775626,0.282146554984897
FOS,Proto-oncogene c-Fos,Mental health,X29003.Recent feelings of depression,34366,-0.086856940618782,0.0962033460527814,-0.275415498882234,0.10170161764467,0.366648953613203
FOS,Proto-oncogene c-Fos,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",34379,0.00726144519075671,0.074885452765536,-0.139514042229694,0.154036932611207,0.922756058735415
FOS,Proto-oncogene c-Fos,Mental health,X29005.Recent feelings of tiredness or low energy,34382,0.0128482880301729,0.0752623007454843,-0.134665821430976,0.160362397491322,0.864455735565756
FOS,Proto-oncogene c-Fos,Mental health,X29006.Recent poor appetite or overeating,34391,-0.0307127944375272,0.115421981376263,-0.256939877935003,0.195514289059948,0.79017939230411
FOS,Proto-oncogene c-Fos,Mental health,X29007.Recent feelings of inadequacy,34363,-0.113781110909008,0.108519689217106,-0.326479701774536,0.0989174799565193,0.294464908767929
FOS,Proto-oncogene c-Fos,Mental health,X29008.Recent trouble concentrating on things,34389,-0.139374006324209,0.106058312560521,-0.34724829894283,0.068500286294413,0.188861784980852
FOS,Proto-oncogene c-Fos,Mental health,X29009.Recent changes in speed or amount of moving or speaking,34384,0.148716851545426,0.182343342584435,-0.208676099920067,0.50610980301092,0.414773854277445
FOS,Proto-oncogene c-Fos,Mental health,X29010.Recent thoughts of suicide or self-harm,34365,-0.0298126476610053,0.204429240424734,-0.430493958893484,0.370868663571473,0.88405845399354
FOS,Proto-oncogene c-Fos,Mental health,X29038#0.Substances taken for depression_None of options listed,35193,0.00644216028736536,0.0223675073799846,-0.0373981541774044,0.0502824747521351,0.773345799916658
FOS,Proto-oncogene c-Fos,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),35193,0.0526791022817743,0.0555613820651667,-0.0562212065659524,0.161579411129501,0.34310431641653
FOS,Proto-oncogene c-Fos,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),35193,0.00354593023115598,0.0226166055133544,-0.0407826165750186,0.0478744770373305,0.87542006796799
FOS,Proto-oncogene c-Fos,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),35193,0.0328839275292484,0.0686953502300185,-0.101758958921588,0.167526813980085,0.632175069727294
FOS,Proto-oncogene c-Fos,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),35193,-0.0401571534926682,0.0561958303037548,-0.150300980888028,0.0699866739026912,0.474888304620882
FOS,Proto-oncogene c-Fos,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),35193,-0.00553268928442835,0.0598307886394897,-0.122801035017828,0.111735656448971,0.926325904021781
FOS,Proto-oncogene c-Fos,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),35193,-0.0206805295794465,0.0643182385681757,-0.146744277173071,0.105383218014178,0.747816610404556
FOS,Proto-oncogene c-Fos,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),35193,-0.0406347833340843,0.0623953001960571,-0.162929571718356,0.0816600050501877,0.514911676747311
FOS,Proto-oncogene c-Fos,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),35193,-0.00628797625523782,0.0398995901719911,-0.0844911729923404,0.0719152204818647,0.874781240908755
FOS,Proto-oncogene c-Fos,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,35193,0.0048884347794557,0.0205009115705148,-0.0352933518987533,0.0450702214576647,0.811540522459485
FOS,Proto-oncogene c-Fos,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,35193,0.0212764315299609,0.035768041186858,-0.0488289291962809,0.0913817922562026,0.551969686277842
FOS,Proto-oncogene c-Fos,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,35193,0.0414075556381047,0.0575489318215394,-0.0713883507321126,0.154203462008322,0.471849166507316
FOS,Proto-oncogene c-Fos,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,35193,0.0259177999406232,0.0792232734353063,-0.129359815992577,0.181195415873824,0.743566747500749
FOS,Proto-oncogene c-Fos,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,35193,0.0262102562721229,0.0555072476782788,-0.0825839491773036,0.135004461721549,0.636804636538327
FOS,Proto-oncogene c-Fos,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,35193,0.066650615581187,0.0774105083536902,-0.0850739807920457,0.21837521195442,0.389271259182404
FOS,Proto-oncogene c-Fos,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,35193,-0.0614038564395523,0.0727020862830856,-0.2038999455544,0.0810922326752954,0.398370391142597
FOS,Proto-oncogene c-Fos,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,35193,0.00684419921301689,0.0439676379746476,-0.0793323712172925,0.0930207696433262,0.876302739263176
FOS,Proto-oncogene c-Fos,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,35193,-0.0115557486587579,0.0424346017622548,-0.0947275681127773,0.0716160707952615,0.78538611405193
FOS,Proto-oncogene c-Fos,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,35193,-0.0134279093236469,0.061442650757025,-0.133855504807416,0.106999686160122,0.827012882847384
FOS,Proto-oncogene c-Fos,Mental health,X29058.Recent feelings or nervousness or anxiety,34303,-0.0555066007620161,0.0902356285246713,-0.232368432670372,0.12135523114634,0.538496582043002
FOS,Proto-oncogene c-Fos,Mental health,X29059.Recent inability to stop or control worrying,34314,-0.12148164922972,0.0916761513943991,-0.301166905962742,0.0582036075033025,0.185191421104497
FOS,Proto-oncogene c-Fos,Mental health,X29060.Recent worrying too much about different things,34312,-0.0343177384392793,0.0849360932747711,-0.200792481257831,0.132157004379272,0.686198814232879
FOS,Proto-oncogene c-Fos,Mental health,X29061.Recent trouble relaxing,34312,-0.0208114384042163,0.0923366060243646,-0.201791186211971,0.160168309403538,0.821687497742929
FOS,Proto-oncogene c-Fos,Mental health,X29062.Recent restlessness,34324,-0.0224684605053631,0.135293779123196,-0.287644267586828,0.242707346576102,0.868107115015334
FOS,Proto-oncogene c-Fos,Mental health,X29063.Recent easy annoyance or irritability,34296,0.0182300904997405,0.0934053792242821,-0.164844452779852,0.201304633779333,0.845266275532751
FOS,Proto-oncogene c-Fos,Mental health,X29064.Recent feelings of foreboding,34299,0.00551965093366311,0.105621298335083,-0.201498093803099,0.212537395670426,0.958324461660374
FOS,Proto-oncogene c-Fos,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,35193,0.00879136954475424,0.0257002450353995,-0.0415811107246287,0.0591638498141372,0.732307657015889
FOS,Proto-oncogene c-Fos,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,35193,-0.0313523995183038,0.0439491350772506,-0.117492704269715,0.0547879052331074,0.47563888071157
FOS,Proto-oncogene c-Fos,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',35193,-0.0445213617913003,0.055542167742468,-0.153384010566538,0.0643412869839369,0.422829043132133
FOS,Proto-oncogene c-Fos,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,35193,0.046769097083771,0.0530867664189049,-0.0572809650972827,0.150819159264825,0.378356622409987
FOS,Proto-oncogene c-Fos,Mental health,X29065#2.Symptoms of panic attack_Sweating,35193,0.0105669864647382,0.0385774834449949,-0.0650448810874518,0.0861788540169282,0.784158675539187
FOS,Proto-oncogene c-Fos,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,35193,0.0185072597346552,0.0425004071837935,-0.0647935383455802,0.10180805781489,0.66324368009175
FOS,Proto-oncogene c-Fos,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,35193,0.0099389960507097,0.0424721079882664,-0.0733063356062925,0.0931843277077118,0.814983408234945
FOS,Proto-oncogene c-Fos,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,35193,-0.0110809370595712,0.0430504138165062,-0.0954597481399233,0.0732978740207809,0.796883124342667
FOS,Proto-oncogene c-Fos,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,35193,-0.000692832408629349,0.0526336132192075,-0.103854714318276,0.102469049501017,0.989497941604598
FOS,Proto-oncogene c-Fos,Mental health,X29076.Felt loved as a child,34297,0.0252855733971597,0.0782435136813456,-0.128071713418278,0.178642860212597,0.74658345465333
FOS,Proto-oncogene c-Fos,Mental health,X29077.Physically abused by family as a child,34317,0.0831032970353332,0.11586322944268,-0.143988632672319,0.310195226742985,0.473250465449288
FOS,Proto-oncogene c-Fos,Mental health,X29078.Felt hated by family member as a child,34302,0.167242951058544,0.11525456105666,-0.0586559886125106,0.393141890729598,0.1468205679799
FOS,Proto-oncogene c-Fos,Mental health,X29079.Sexually molested as a child,34263,0.0210658669349039,0.147024321714267,-0.26710180362506,0.309233537494868,0.886073555947812
FOS,Proto-oncogene c-Fos,Mental health,X29080.Someone to take to doctor when needed as a child,34281,0.0621538404260697,0.108743866762729,-0.150984138428879,0.275291819281018,0.567644146859985
FOS,Proto-oncogene c-Fos,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,34307,0.205319035555804,0.169907173459152,-0.127699024424133,0.538337095535741,0.226942077784503
FOS,Proto-oncogene c-Fos,Mental health,X29082.Belittlement by partner or ex-partner as an adult,34274,-0.0826296283852905,0.127314350211765,-0.33216575480035,0.166906498029769,0.516354445063825
FOS,Proto-oncogene c-Fos,Mental health,X29083.Physical violence by partner or ex-partner as an adult,34312,-0.0495112056751183,0.145982565904192,-0.335637034847335,0.236614623497098,0.734504363732347
FOS,Proto-oncogene c-Fos,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,34299,0.000591175055602031,0.203844320838695,-0.398943693788241,0.400126043899445,0.997686147531588
FOS,Proto-oncogene c-Fos,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,34299,-0.0345979478702284,0.187490700558197,-0.402079720964295,0.332883825223839,0.853603817205571
FOS,Proto-oncogene c-Fos,Mental health,X29086.Experienced a violent or sexual assault,34313,-0.186663962645058,0.179482940258157,-0.538450525551046,0.165122600260931,0.2983846154983
FOS,Proto-oncogene c-Fos,Mental health,X29087.Experienced a life-threatening injury or illness,34310,0.00408952425011685,0.0872749099407923,-0.166969299233836,0.17514834773407,0.962628263515171
FOS,Proto-oncogene c-Fos,Mental health,X29088.Experienced a marital separation or divorce,34311,-0.0305338906600623,0.0876221209310394,-0.202273247684899,0.141205466364775,0.727499777748523
FOS,Proto-oncogene c-Fos,Mental health,X29089.Experienced the death of a spouse or partner,34320,0.133415238350098,0.0952143316863198,-0.0532048517550891,0.320035328455284,0.161211945674445
FOS,Proto-oncogene c-Fos,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,34311,0.0166324636782458,0.112648341116256,-0.204158284909616,0.237423212266107,0.882625259219255
FOS,Proto-oncogene c-Fos,Lifestyle factors,X29091.Frequency of drinking alcohol,34307,0.0174703077745994,0.0697889219373325,-0.119315979222572,0.154256594771771,0.802341701584962
FOS,Proto-oncogene c-Fos,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,33676,0.0156773168024703,0.0877780352389729,-0.156367632265917,0.187722265870857,0.858258443346884
FOS,Proto-oncogene c-Fos,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,33697,-0.0488340186092971,0.0908363180050427,-0.226873201899181,0.129205164680587,0.590876666324359
FOS,Proto-oncogene c-Fos,Mental health,X29104.Ever used cannabis,34309,-0.333370582819655,0.130978751884686,-0.590088936513641,-0.0766522291256694,0.0109498182056414
FOS,Proto-oncogene c-Fos,Mental health,X29108.Ever thought that life not worth living,34284,-0.176149826407594,0.095439599673716,-0.363211441768078,0.0109117889528889,0.0649984584525336
FOS,Proto-oncogene c-Fos,Mental health,X29109.Ever contemplated self-harm,34302,0.202350742369598,0.141672491349658,-0.0753273406757315,0.480028825414928,0.153266835351975
FOS,Proto-oncogene c-Fos,Mental health,X29111.Ever self-harmed,34309,0.07461729193495,0.254398189013647,-0.424003158531797,0.573237742401697,0.769297835713342
FOS,Proto-oncogene c-Fos,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,34296,-0.0796468053162485,0.145834012658932,-0.365481470127754,0.206187859495257,0.584988794170014
FOS,Proto-oncogene c-Fos,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,35713,-0.0231592092032532,0.0614539054088211,-0.143608863804542,0.0972904453980361,0.706293658694632
FOS,Proto-oncogene c-Fos,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,35713,0.0229149372723028,0.0455772091833001,-0.0664163927269654,0.112246267271571,0.615141679229872
FOS,Proto-oncogene c-Fos,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,35713,-0.0472782286008563,0.0555701742690804,-0.156195770168254,0.0616393129665412,0.394920464549655
FOS,Proto-oncogene c-Fos,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,35713,-0.0456941808050522,0.0833737583343327,-0.209106747140344,0.11771838553024,0.583666515681885
FOS,Proto-oncogene c-Fos,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,34288,0.0864593911691139,0.0822951916149179,-0.0748391843961253,0.247757966734353,0.293491837218165
FOS,Proto-oncogene c-Fos,Health and medical history,X29153.Pain or discomfort today,34300,0.0522390743131895,0.0742757403103187,-0.093341376695035,0.197819525321414,0.481892959820518
FOS,Proto-oncogene c-Fos,Mental health,X29154.Anxiety or depression today,34300,-0.0995505133810487,0.0955822537451975,-0.286891730721636,0.0877907039595385,0.297685147590801
FOS,Proto-oncogene c-Fos,Mental health,X29166.Frequency of confiding in someone close,34148,0.00528402596626909,0.0734393147558547,-0.138657030955206,0.149225082887744,0.942643876739219
FOS,Proto-oncogene c-Fos,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,34285,0.0111466179505828,0.0109205064640567,-0.0102575747189684,0.032550810620134,0.307442621081152
FOS,Proto-oncogene c-Fos,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,34285,-0.000951787653350577,0.0111847979846339,-0.0228739917032331,0.020970416396532,0.932187983968159
FOS,Proto-oncogene c-Fos,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,34285,-0.00936445005963991,0.013945375978346,-0.036697386977198,0.0179684868579182,0.501926586559497
FOS,Proto-oncogene c-Fos,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,34285,-0.016343693288686,0.012918049353092,-0.0416630700207463,0.00897568344337438,0.205863726607523
FOS,Proto-oncogene c-Fos,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,34285,-0.00622395752901117,0.0217685559754437,-0.0488903272408809,0.0364424121828585,0.774954827577716
FOS,Proto-oncogene c-Fos,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,34285,0.00151697669124412,0.0105786523632135,-0.0192171819406544,0.0222511353231426,0.885980111890779
FOS,Proto-oncogene c-Fos,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,34281,-0.00820033715920788,0.011332215190384,-0.0304114789323605,0.0140108046139448,0.469325851259435
FOS,Proto-oncogene c-Fos,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,34281,0.0139007560298884,0.017460094189509,-0.0203210285815492,0.0481225406413259,0.425985266475512
FOS,Proto-oncogene c-Fos,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,34281,0.0204883085003047,0.0254089023065261,-0.0293131400204865,0.0702897570210959,0.420082388711416
FOS,Proto-oncogene c-Fos,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,34281,-0.00577393069015047,0.0202590713013854,-0.0454817104408658,0.0339338490605648,0.775652137516173
FOS,Proto-oncogene c-Fos,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,34281,-0.095353054287371,0.0329139675144736,-0.159864430615739,-0.0308416779590027,0.00378310194336408
FOS,Proto-oncogene c-Fos,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,34281,0.0196546116543083,0.0153017118844446,-0.0103367436392031,0.0496459669478197,0.199035545772453
FOS,Proto-oncogene c-Fos,Mental health,X29171.Frequency of feeling 'in tune' with people,34199,0.0471410453932476,0.0940854326601938,-0.137266402620732,0.231548493407228,0.616361418728175
FOS,Proto-oncogene c-Fos,Mental health,X29172.Freuency of feeling that lacks companionship,34267,0.00162892429147825,0.0847536321852116,-0.164488194791537,0.167746043374493,0.984666740224038
FOS,Proto-oncogene c-Fos,Mental health,X29173.Frequency of feeling left out,34234,0.0539221122269603,0.0898406301465297,-0.122165522860238,0.230009747314159,0.548401679340154
FOS,Proto-oncogene c-Fos,Mental health,X29174.Frequency of feeling isolated from others,34261,0.055125637735769,0.0932950081589925,-0.127732578255856,0.237983853727394,0.55463089800164
FOS,Proto-oncogene c-Fos,Mental health,X29175.Tendency to bounce back quickly after hard times,34296,0.0789873068985502,0.0741435340032041,-0.0663340197477299,0.22430863354483,0.286777211188951
FOS,Proto-oncogene c-Fos,Mental health,X29176.Ability to make it through stressful events,34296,-0.0678410157500021,0.0716993041176598,-0.208371651820615,0.072689620320611,0.344097579188291
FOS,Proto-oncogene c-Fos,Mental health,X29177.Quick recovery from stressful events,34296,0.0581586924795269,0.0733695405975023,-0.0856456070915776,0.201962992050631,0.428000171451221
FOS,Proto-oncogene c-Fos,Mental health,X29178.Hard to snap back when something bad happens,34296,-0.0698642872749434,0.0722335994664146,-0.211442142229116,0.0717135676792291,0.333490280454517
FOS,Proto-oncogene c-Fos,Mental health,X29179.Comes through difficult times with little trouble,34296,0.149728982829487,0.0729650628871601,0.00671745957065356,0.292740506088321,0.0402143890476967
FOS,Proto-oncogene c-Fos,Mental health,X29180.Tendency to take a long time to get over setbacks,34296,-0.0227786100872838,0.0730538840917216,-0.165964222907058,0.120407002732491,0.755201016921509
FOS,Proto-oncogene c-Fos,Mental health,X29181.General happiness,34273,-0.0429365592696751,0.0755419289678452,-0.190998740046652,0.105125621507302,0.569801776799121
FOS,Proto-oncogene c-Fos,Mental health,X29182.Belief that own life is meaningful,34191,0.0145994930435707,0.0756203167346786,-0.133616327756399,0.162815313843541,0.846917398953244
FOS,Proto-oncogene c-Fos,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,34543,0.034472600755963,0.0723331800540392,-0.107300432149954,0.17624563366188,0.63368016524037
FOS,Proto-oncogene c-Fos,Health and medical history,X2946.Father's age,30012,0.0268519990689206,0.0250303252893421,-0.0222074384981899,0.0759114366360311,0.283686810122384
FOS,Proto-oncogene c-Fos,Health and medical history,X2966.Age high blood pressure diagnosed,35503,-0.000844387432159617,0.00492570090105615,-0.0104987611982297,0.00880998633391044,0.863895231125787
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30000.White blood cell (leukocyte) count,47966,0.00778671818646885,0.00286284604834427,0.00217553993171408,0.0133978964412236,0.00653573821890754
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,47967,-0.00357372190893633,0.00305752429956858,-0.00956646953609075,0.00241902571821808,0.242487528263523
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30020.Haemoglobin concentration,47967,-0.00697385040415741,0.00330713923108192,-0.013455843297078,-0.00049185751123685,0.0349814519824968
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30030.Haematocrit percentage,47967,-0.00373094315268671,0.0032142520370145,-0.0100308771452351,0.00256899083986171,0.245758329003399
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30040.Mean corpuscular volume,47967,0.000922180212398205,0.00277661532381032,-0.00451998582227002,0.00636434624706644,0.739799438405671
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30050.Mean corpuscular haemoglobin,47967,-0.00286547737627152,0.00278591967204934,-0.00832587993348822,0.00259492518094518,0.303701111548203
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,47967,-0.00706283187665364,0.00272060945658298,-0.0123952264115563,-0.001730437341751,0.00943764258656444
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,47967,0.01016386094626,0.00280525964095737,0.00466555204998352,0.0156621698425364,0.000291811108903701
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30080.Platelet count,47967,0.00238036262704106,0.00275647313508132,-0.00302232471771832,0.00778304997180043,0.387844129945859
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30090.Platelet crit,47967,0.00285439439647229,0.00281155103127311,-0.002656245624823,0.00836503441776759,0.310005313560675
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,47967,-7.43503673650987e-05,0.00261703458711639,-0.00520373815811323,0.00505503742338303,0.977335324167853
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30110.Platelet distribution width,47967,-0.00240852794751957,0.00272630782917513,-0.00775209129270283,0.00293503539766369,0.377010185334792
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30120.Lymphocyte count,47935,0.000254107880007869,0.00269333512429749,-0.00502482896361521,0.00553304472363095,0.924834586041786
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30130.Monocyte count,47935,0.000976928320323172,0.00275734781769121,-0.0044274734023516,0.00638133004299794,0.723118057019547
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30140.Neutrophill count,47935,0.00858983332470381,0.00283911448245208,0.00302516893909774,0.0141544977103099,0.0024853214447534
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30150.Eosinophill count,47935,0.00175790971184467,0.00270575624364667,-0.00354537252570279,0.00706119194939214,0.515898790784229
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30160.Basophill count,47935,0.0510771301331977,0.0411268051011231,-0.0295314078650037,0.131685668131399,0.214273293552631
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30170.Nucleated red blood cell count,47935,0.0999335935521384,0.209259568136349,-0.310215159995105,0.510082347099382,0.632970356688969
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30180.Lymphocyte percentage,47936,-0.00543496297420656,0.00268231160864897,-0.0106922937271586,-0.000177632221254572,0.042756015377544
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30190.Monocyte percentage,47936,-0.00376980998890525,0.00272694458337589,-0.009114621372322,0.0015750013945115,0.166856184083323
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30200.Neutrophill percentage,47936,0.00591719168784195,0.00266787135998126,0.000688163822278685,0.0111462195534052,0.0265705319527484
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30210.Eosinophill percentage,47936,0.000134904205997029,0.00269094352185827,-0.00513934509684519,0.00540915350883924,0.960017193152467
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30220.Basophill percentage,47936,0.00230370096778555,0.00268866017538571,-0.00296607297597044,0.00757347491154155,0.391554676971613
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30230.Nucleated red blood cell percentage,47935,0.0986528976010153,0.209439764275997,-0.311849040379938,0.509154835581968,0.637623139310824
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30240.Reticulocyte percentage,47620,0.00134272425302826,0.00290886810358379,-0.00435865722999598,0.0070441057360525,0.644375927872343
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30250.Reticulocyte count,47620,0.000579642282455062,0.00296441145767041,-0.00523060417457895,0.00638988873948907,0.84497732944645
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30260.Mean reticulocyte volume,47620,0.00282536255214492,0.00271892372514061,-0.00250372794913067,0.00815445305342051,0.298749818937421
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30270.Mean sphered cell volume,47620,-0.00152238899248169,0.00275515448929583,-0.00692249179150152,0.00387771380653814,0.580571235294354
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30280.Immature reticulocyte fraction,47620,-0.00123846682249856,0.00287293997649583,-0.00686942917643039,0.00439249553143327,0.666415281260045
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30290.High light scatter reticulocyte percentage,47620,0.000959225644400907,0.0029643911520378,-0.00485098101359319,0.006769432302395,0.746257671971364
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30300.High light scatter reticulocyte count,47620,0.000421413573838393,0.00300503864197853,-0.00546846216443953,0.00631128931211632,0.88847533140364
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30500.Microalbumin in urine,35866,0.0150304870738188,0.00444790206252455,0.00631259903127069,0.0237483751163669,0.000731055244100961
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,47941,-0.0013661673918604,0.00299368816908649,-0.00723379620326992,0.00450146141954912,0.648144130415762
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30520.Potassium in urine,47911,-0.00426491472603389,0.00280505054892493,-0.00976281380192676,0.00123298434985898,0.12841699102781
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30530.Sodium in urine,47893,-0.000613168052290916,0.00294918576255077,-0.00639357214689042,0.00516723604230859,0.835300753165088
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30600.Albumin,46085,-0.00857438621482213,0.00288213150263523,-0.0142233639599872,-0.00292540846965709,0.00293388051391975
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30610.Alkaline phosphatase,47593,0.0030885439099889,0.00287015845694929,-0.00253696666563171,0.0087140544856095,0.281901881469833
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30620.Alanine aminotransferase,47596,0.00610665326668332,0.00304236507876831,0.000143617712297434,0.0120696888210692,0.0447423349783995
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30630.Apolipoprotein A,45963,-0.00621062541180099,0.00317800538256714,-0.0124395159616326,1.82651380306025e-05,0.0506879433357636
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30640.Apolipoprotein B,47513,-0.00526791208697898,0.00265685317448888,-0.0104753443089772,-6.04798649807819e-05,0.0474087403902492
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30650.Aspartate aminotransferase,47540,0.0176984124370007,0.00290472903450513,0.0120051435293707,0.0233916813446308,1.13049665037685e-09
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30660.Direct bilirubin,44914,0.000374116600807803,0.00306155395546409,-0.00562652915190182,0.00637476235351742,0.90274355751904
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30670.Urea,47587,0.00622115956415072,0.00285747391100739,0.000620510698576235,0.0118218084297252,0.0294817801569385
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30680.Calcium,46083,-0.00261805051643043,0.00280927800044487,-0.00812423539730238,0.00288813436444152,0.351386011209776
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30690.Cholesterol,47600,-0.00602035756445274,0.00268151358356793,-0.0112761241882459,-0.000764590940659594,0.0247713482766231
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30700.Creatinine,47593,0.0111928167287292,0.00322791145044067,0.00486611028586551,0.0175195231715929,0.00052650348203929
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30710.C-reactive protein,47543,0.0104959284860819,0.00302898830090892,0.00455911141630043,0.0164327455558634,0.000531127476217494
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30720.Cystatin C,47606,0.019880020232665,0.00315365977446147,0.0136988470747205,0.0260611933906095,2.97049563396746e-10
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30730.Gamma glutamyltransferase,47594,0.00325778369829606,0.00307119209821933,-0.00276175281421383,0.00927732021080595,0.288814984768304
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30740.Glucose,46069,-0.000467842916852767,0.00287870024470262,-0.00611009539646989,0.00517440956276436,0.870899268670636
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),47595,0.0064366455425383,0.00295420708498,0.000646399655977493,0.0122268914290991,0.0293586916438064
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30760.HDL cholesterol,46076,-0.00732670577056984,0.00325713951237517,-0.0137106992148252,-0.000942712326314502,0.0244980137336945
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30770.IGF-1,47494,-0.000554629550744144,0.00281545373981339,-0.00607291888077839,0.00496365977929011,0.843833849132755
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30780.LDL direct,47557,-0.00503849124236211,0.00262866609739325,-0.0101906767932529,0.000113694308528662,0.0552854201036507
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30790.Lipoprotein A,43870,0.00782552670811656,0.00301200592836947,0.00192199508851241,0.0137290583277207,0.00938317575833039
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30810.Phosphate,46053,0.0115764169433099,0.00300025012446833,0.00569592669935197,0.0174569071872678,0.000114517398586782
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30830.SHBG,45931,0.000345312797369334,0.00348498548245319,-0.00648525874823891,0.00717588434297758,0.921071282435849
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30840.Total bilirubin,47524,-0.000336674008401148,0.00296107683933166,-0.0061403846134912,0.0054670365966889,0.909476972387955
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30850.Testosterone,45419,-0.00738343052343974,0.0046570702476943,-0.0165112882089206,0.00174442716204108,0.112889540323761
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30860.Total protein,46070,-0.00293361447242002,0.00281136464750367,-0.0084438891815272,0.00257666023668717,0.29673906119847
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30870.Triglycerides,47589,0.00144299803025487,0.00306363360054765,-0.00456172382681853,0.00744771988732827,0.637640118926848
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30880.Urate,47570,0.00687233647776522,0.00333821894463598,0.000329427346278702,0.0134152456092517,0.0395386255207599
FOS,Proto-oncogene c-Fos,Blood and urine assays,X30890.Vitamin D,46662,-0.00281308645398869,0.00311090047655965,-0.00891045138804561,0.00328427848006823,0.365866002425098
FOS,Proto-oncogene c-Fos,Physical measures,X3137.Number of measurements made,46403,-0.0441573660344798,0.0484599654161408,-0.139138898250116,0.0508241661811563,0.362195750515612
FOS,Proto-oncogene c-Fos,Physical measures,X3143.Ankle spacing width,40080,-0.00022482917457077,0.0048323546447334,-0.00969624427824824,0.0092465859291067,0.962892022897203
FOS,Proto-oncogene c-Fos,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",40080,-0.00206686248456424,0.00375777776109319,-0.00943210689630689,0.00529838192717842,0.582315195329065
FOS,Proto-oncogene c-Fos,Physical measures,X3146.Speed of sound through heel,40080,-0.00415681171024208,0.00361002781392774,-0.0112324662255404,0.00291884280505628,0.249567296253488
FOS,Proto-oncogene c-Fos,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",40080,-0.00350217559973705,0.00365359076916576,-0.0106632135073019,0.00365886230782783,0.337803169750207
FOS,Proto-oncogene c-Fos,Physical measures,X3148.Heel bone mineral density (BMD),40070,-0.00323322508166943,0.00365985535178958,-0.010406541571177,0.00394009140783814,0.37702365210419
FOS,Proto-oncogene c-Fos,Health and medical history,X3526.Mother's age at death,45202,-0.00405888886188252,0.00279234114159366,-0.00953187749940608,0.00141409977564105,0.146082624465712
FOS,Proto-oncogene c-Fos,Health and medical history,X3581.Age at menopause (last menstrual period),37006,-0.00295789762826583,0.0038879208946605,-0.0105782225818004,0.00466242732526876,0.446804500992451
FOS,Proto-oncogene c-Fos,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",32217,-0.0037539873276729,0.00595008487303539,-0.0154161536788223,0.00790817902347648,0.528144949175256
FOS,Proto-oncogene c-Fos,Physical measures,X4100.Ankle spacing width (left),35593,-0.00646784473731145,0.00608199210403108,-0.0183885492612124,0.00545285978658945,0.287621766023716
FOS,Proto-oncogene c-Fos,Physical measures,X4101.Heel broadband ultrasound attenuation (left),35591,0.00201187132472381,0.00475469135040832,-0.00730732372207649,0.0113310663715241,0.672211758779428
FOS,Proto-oncogene c-Fos,Physical measures,X4103.Speed of sound through heel (left),35593,0.00226730844188377,0.00454876171950245,-0.00664826452834102,0.0111828814121086,0.618187416994701
FOS,Proto-oncogene c-Fos,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",35593,0.00215062795825066,0.00460928080113272,-0.00688356241196948,0.0111848183284708,0.640811668394728
FOS,Proto-oncogene c-Fos,Physical measures,X4105.Heel bone mineral density (BMD) (left),35590,0.00218415154936987,0.00460559453038224,-0.00684281373017932,0.0112111168289191,0.635345828425091
FOS,Proto-oncogene c-Fos,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",35593,0.00215386919996499,0.00460926393692249,-0.00688028811640308,0.0111880265163331,0.640307350542399
FOS,Proto-oncogene c-Fos,Physical measures,X4119.Ankle spacing width (right),35590,-0.000758476549766407,0.006011912778973,-0.0125418255965535,0.0110248724970207,0.899607444088761
FOS,Proto-oncogene c-Fos,Physical measures,X4120.Heel broadband ultrasound attenuation (right),35589,0.000139052968754701,0.00471889374504364,-0.00910997877153083,0.00938808470904023,0.976492832971194
FOS,Proto-oncogene c-Fos,Physical measures,X4122.Speed of sound through heel (right),35590,0.00220050945618744,0.00451076462387086,-0.00664058920659944,0.0110416081189743,0.625683345884734
FOS,Proto-oncogene c-Fos,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",35590,0.00136545127931156,0.0045727110374744,-0.00759706235413826,0.0103279649127614,0.765248330271443
FOS,Proto-oncogene c-Fos,Physical measures,X4124.Heel bone mineral density (BMD) (right),35586,0.00126754610514132,0.00456768372442454,-0.00768511399473079,0.0102202062050134,0.781402848509038
FOS,Proto-oncogene c-Fos,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",35590,0.00136566045941974,0.00457269625496748,-0.00759682420031652,0.010328145119156,0.765212687451678
FOS,Proto-oncogene c-Fos,Physical measures,X4194.Pulse rate,35889,0.00260817837020377,0.00435193895924033,-0.00592162198990727,0.0111379787303148,0.54898372802371
FOS,Proto-oncogene c-Fos,Physical measures,X4195.Pulse wave reflection index,35889,0.00395276172357786,0.00469543346130173,-0.00525028786057354,0.0131558113077293,0.399912592655977
FOS,Proto-oncogene c-Fos,Physical measures,X4196.Pulse wave peak to peak time,35885,0.000965347521682987,0.00430051417027133,-0.00746366025204882,0.00939435529541479,0.822396452751456
FOS,Proto-oncogene c-Fos,Physical measures,X4198.Position of the pulse wave peak,35889,0.00360566345202579,0.00457549510026419,-0.00536230694449202,0.0125736338485436,0.430702449525828
FOS,Proto-oncogene c-Fos,Physical measures,X4199.Position of pulse wave notch,35889,-0.000489652142621949,0.0043608058194848,-0.00903683154881216,0.00805752726356826,0.910600971791405
FOS,Proto-oncogene c-Fos,Physical measures,X4200.Position of the shoulder on the pulse waveform,35889,0.00346146074046479,0.00450366462771213,-0.005365721929851,0.0122886434107806,0.442165285276191
FOS,Proto-oncogene c-Fos,Physical measures,X4269.Number of triplets attempted (left),35734,-0.079412102389498,0.189874951407683,-0.451567007148557,0.292742802369562,0.675790024357817
FOS,Proto-oncogene c-Fos,Physical measures,X4270.Volume level set by participant (left),35662,0.0104773559070378,0.064512975740832,-0.115968076544993,0.136922788359069,0.870990470343763
FOS,Proto-oncogene c-Fos,Physical measures,X4276.Number of triplets attempted (right),35729,0.0434019348643985,0.185501727010608,-0.320181450076394,0.406985319805191,0.815015211555564
FOS,Proto-oncogene c-Fos,Physical measures,X4277.Volume level set by participant (right),35654,-0.00705690983876903,0.0639842141619433,-0.132465969596178,0.11835214991864,0.91218168920022
FOS,Proto-oncogene c-Fos,Cognitive function,X4288.Time to answer,35892,0.00117659118967217,0.00519462444932377,-0.00900487273100243,0.0113580551103468,0.820818160709348
FOS,Proto-oncogene c-Fos,Cognitive function,X4290.Duration screen displayed,35892,-0.0131256912939412,0.00481943784623126,-0.0225717894725545,-0.00367959311532793,0.00647635780034359
FOS,Proto-oncogene c-Fos,Physical measures,X46.Hand grip strength (left),48454,-0.00717351750458735,0.00388159707772593,-0.0147814477769302,0.000434412767755469,0.0646055106309611
FOS,Proto-oncogene c-Fos,Physical measures,X47.Hand grip strength (right),48474,-0.0088299284458213,0.00385572945638835,-0.0163871581803425,-0.00127269871130014,0.0220274346004596
FOS,Proto-oncogene c-Fos,Physical measures,X48.Waist circumference,48531,0.0148542211185699,0.00586803915179933,0.00335286438104324,0.0263555778560966,0.0113694110575507
FOS,Proto-oncogene c-Fos,Health and medical history,X4803.Tinnitus,35805,-0.0131507733987274,0.0722891576886991,-0.154837522468578,0.128535975671123,0.855651850416521
FOS,Proto-oncogene c-Fos,Working and living environment,X4825.Noisy workplace,35879,0.0353840379213362,0.0835669071233665,-0.128407100040462,0.199175175883135,0.672001275539762
FOS,Proto-oncogene c-Fos,Working and living environment,X4836.Loud music exposure frequency,35837,-0.0518492999958306,0.14145673255313,-0.329104495799966,0.225405895808305,0.7139751699786
FOS,Proto-oncogene c-Fos,Physical measures,X49.Hip circumference,48526,-0.00144228769388074,0.00476676346560754,-0.0107851440864715,0.00790056869871004,0.762219544538423
FOS,Proto-oncogene c-Fos,Physical measures,X50.Standing height,48515,0.00168920761273827,0.00377205775027373,-0.00570402557779825,0.00908244080327478,0.654287227640414
FOS,Proto-oncogene c-Fos,Health and medical history,X5057.Number of older siblings,34860,-0.019339653527965,0.069728608089931,-0.15600772538423,0.1173284183283,0.781516821070497
FOS,Proto-oncogene c-Fos,Physical measures,X51.Seated height,48441,-0.00141674918513333,0.00353751417038766,-0.00835027695909314,0.00551677858882648,0.68879798277378
FOS,Proto-oncogene c-Fos,Eye measures,X5181.Ever had eye surgery,33714,-0.10811256662565,0.146507921653776,-0.39526809306705,0.179042959815751,0.460595412246652
FOS,Proto-oncogene c-Fos,Eye measures,X5186.Duration visual-acuity screen displayed (right),33701,0.00228354212201274,0.00519813039725225,-0.00790479345660167,0.0124718777006272,0.660464755474532
FOS,Proto-oncogene c-Fos,Eye measures,X5188.Duration visual-acuity screen displayed (left),33700,0.0033684316312113,0.00536746625441988,-0.00715180222745166,0.0138886654898743,0.53032102675997
FOS,Proto-oncogene c-Fos,Eye measures,X5190.Duration at which refractometer first shown (right),33641,0.00299081807036938,0.00549117636924964,-0.00777188761335991,0.0137535237540987,0.586015448783654
FOS,Proto-oncogene c-Fos,Eye measures,X5193.Duration at which refractometer first shown (left),33639,0.00572967700851503,0.00555112097723984,-0.00515052010687506,0.0166098741239051,0.302050626616237
FOS,Proto-oncogene c-Fos,Eye measures,"X5199.logMAR, initial (right)",33686,0.117428336231361,0.0824757008360681,-0.0442240374073328,0.279080709870054,0.154575835887014
FOS,Proto-oncogene c-Fos,Eye measures,X5200.Final number of letters displayed (right),33686,-0.133703832531353,0.505253630092639,-1.12400094751293,0.856593282450218,0.791308842487989
FOS,Proto-oncogene c-Fos,Eye measures,"X5201.logMAR, final (right)",33634,0.00637444983431482,0.00579462147809254,-0.00498300826274656,0.0177319079313762,0.271364226189054
FOS,Proto-oncogene c-Fos,Eye measures,X5202.Number of rounds to result (right),33686,0.013772328480672,0.0768637382745001,-0.136880598537348,0.164425255498692,0.857805654554289
FOS,Proto-oncogene c-Fos,Eye measures,"X5206.logMAR, initial (left)",33681,0.0324778464877537,0.0831069905865124,-0.130411855061811,0.195367548037318,0.695966882890208
FOS,Proto-oncogene c-Fos,Eye measures,X5207.Final number of letters displayed (left),33681,-0.27841143104491,0.44817073220657,-1.15682606616979,0.600003204079967,0.53448820096136
FOS,Proto-oncogene c-Fos,Eye measures,"X5208.logMAR, final (left)",33630,0.00177171960464588,0.00570622902935204,-0.00941248929288412,0.0129559285021759,0.756203941812345
FOS,Proto-oncogene c-Fos,Eye measures,X5209.Number of rounds to result (left),33679,0.0184884577182192,0.0766532418126399,-0.131751896234555,0.168728811670993,0.809414239267684
FOS,Proto-oncogene c-Fos,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",33475,-0.00872913564547615,0.00537334844389242,-0.0192608985955053,0.00180262730455299,0.104337553676391
FOS,Proto-oncogene c-Fos,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",33475,-0.0109693722157837,0.00540540741295465,-0.0215639707451748,-0.000374773686392594,0.0424861190821499
FOS,Proto-oncogene c-Fos,Eye measures,X5256.Corneal hysteresis (right),33475,-0.00155616814759925,0.00541284895717199,-0.0121653521036564,0.00905301580845785,0.77374708440971
FOS,Proto-oncogene c-Fos,Eye measures,X5257.Corneal resistance factor (right),33475,-0.00710028966928703,0.00545142294117286,-0.0177850786339858,0.00358449929541178,0.192827407293358
FOS,Proto-oncogene c-Fos,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",33467,-0.00614035784743039,0.00536772130604513,-0.0166610916072789,0.00438037591241806,0.252712079021449
FOS,Proto-oncogene c-Fos,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",33467,-0.00471342295109325,0.005389017447485,-0.0152758971481638,0.00584905124597735,0.381821726429799
FOS,Proto-oncogene c-Fos,Eye measures,X5264.Corneal hysteresis (left),33467,0.00397367284760273,0.00547616905385251,-0.00675961849794819,0.0147069641931537,0.468105330321972
FOS,Proto-oncogene c-Fos,Eye measures,X5265.Corneal resistance factor (left),33467,0.000729872372050793,0.00548331900752609,-0.0100174328827003,0.0114771776268019,0.894114417121457
FOS,Proto-oncogene c-Fos,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,33764,-0.0301853315545862,0.446522107154436,-0.905368661577281,0.844997998468108,0.946106234045073
FOS,Proto-oncogene c-Fos,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",48486,0.00715014135042854,0.0143267570084241,-0.0209303023860827,0.0352305850869398,0.617731497294436
FOS,Proto-oncogene c-Fos,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",48486,0.0224809760621212,0.0152099554969186,-0.00733053671183935,0.0522924888360817,0.139412456985628
FOS,Proto-oncogene c-Fos,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",48486,-0.00101346362065307,0.0396603227760034,-0.0787476962616198,0.0767207690203137,0.979613668218837
FOS,Proto-oncogene c-Fos,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",48486,-0.007673468686107,0.00615025721701214,-0.0197279728314508,0.0043810354592368,0.212168430423277
FOS,Proto-oncogene c-Fos,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",48486,0.00255227286675894,0.00579400016857387,-0.00880396746364584,0.0139085131971637,0.659577974115856
FOS,Proto-oncogene c-Fos,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",36776,-0.0195321853302528,0.00835852383900222,-0.0359148920546972,-0.00314947860580847,0.0194755693121438
FOS,Proto-oncogene c-Fos,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",36776,0.0211347473617234,0.0177927778007753,-0.0137390971277962,0.056008591851243,0.234938661442177
FOS,Proto-oncogene c-Fos,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",36776,-0.0210420132519902,0.0216420196545192,-0.0634603717748478,0.0213763452708673,0.330944346546595
FOS,Proto-oncogene c-Fos,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",36776,0.0217792500808135,0.011906287136026,-0.00155707270579746,0.0451155728674244,0.0674055145552324
FOS,Proto-oncogene c-Fos,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,48545,-0.00671458005552934,0.0118796425351979,-0.0299986794245172,0.0165695193134585,0.571932490646444
FOS,Proto-oncogene c-Fos,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,48545,-0.00671458005552934,0.0118796425351979,-0.0299986794245172,0.0165695193134585,0.571932490646444
FOS,Proto-oncogene c-Fos,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),48545,-0.00380660940043217,0.00960661911925934,-0.0226355828741805,0.0150223640733161,0.691926008809372
FOS,Proto-oncogene c-Fos,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',48545,0.00693943540684432,0.0163860426831501,-0.0251772082521299,0.0390560790658186,0.671937594477996
FOS,Proto-oncogene c-Fos,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),48545,0.0244922343933627,0.0415152858305941,-0.0568777258346017,0.105862194621327,0.555226351945197
FOS,Proto-oncogene c-Fos,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),48545,0.012456583098568,0.0272086433647551,-0.040872357896352,0.065785524093488,0.647088966036698
FOS,Proto-oncogene c-Fos,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,48545,-0.0611643494108727,0.0435491697489031,-0.146520722118723,0.0241920232969775,0.160189201738633
FOS,Proto-oncogene c-Fos,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,48486,-0.0148946755454156,0.00883187940510329,-0.0322051591794181,0.00241580808858683,0.0917220029678503
FOS,Proto-oncogene c-Fos,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,48486,-0.013649985043266,0.0148470958218427,-0.0427502928540776,0.0154503227675456,0.357913198315403
FOS,Proto-oncogene c-Fos,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,48486,-0.00209838506740315,0.00879755586112521,-0.0193415945552086,0.0151448244204023,0.811481039911064
FOS,Proto-oncogene c-Fos,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,48486,0.0187800063484771,0.0124298627635617,-0.00558252466810376,0.043142537365058,0.130835912235898
FOS,Proto-oncogene c-Fos,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,48486,-0.0144732900926154,0.015081421486264,-0.0440328762056929,0.0150862960204621,0.337229937362397
FOS,Proto-oncogene c-Fos,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,48486,0.000966200184126496,0.00594606938392637,-0.0106880958083692,0.0126204961766222,0.870918609516652
FOS,Proto-oncogene c-Fos,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,37201,0.00678966653798176,0.0133917413298218,-0.019458146468469,0.0330374795444326,0.612165967866301
FOS,Proto-oncogene c-Fos,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,37201,0.00141903500370204,0.0114686959431332,-0.021059609044839,0.0238976790522431,0.901531248179233
FOS,Proto-oncogene c-Fos,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,37201,-0.0214379357052048,0.0164724922086182,-0.0537240204340964,0.0108481490236868,0.19314584358272
FOS,Proto-oncogene c-Fos,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,37201,-0.00826754056540152,0.01288042088514,-0.0335131655002758,0.0169780843694728,0.520976734657206
FOS,Proto-oncogene c-Fos,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,48476,-0.01165044366781,0.0202974804212199,-0.0514335052934011,0.0281326179577811,0.565984834675203
FOS,Proto-oncogene c-Fos,Health and medical history,X6151#2.Fractured bone site(s)_Leg,48476,0.0264285698202621,0.0322639669318551,-0.0368088053661739,0.0896659450066982,0.412719072091951
FOS,Proto-oncogene c-Fos,Health and medical history,X6151#3.Fractured bone site(s)_Hip,48476,0.0747867487450813,0.0476817252536406,-0.0186694327520542,0.168242930242217,0.116790863171276
FOS,Proto-oncogene c-Fos,Health and medical history,X6151#4.Fractured bone site(s)_Spine,48476,-0.000125719337954079,0.0529218621518026,-0.103852569155487,0.103601130479579,0.998104599502571
FOS,Proto-oncogene c-Fos,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,48476,-0.00909430837801546,0.0169964125557732,-0.0424072769873309,0.0242186602313,0.592606081745958
FOS,Proto-oncogene c-Fos,Health and medical history,X6151#6.Fractured bone site(s)_Arm,48476,0.0338976756605129,0.0234566856221643,-0.0120774281589292,0.079872779479955,0.148441029879577
FOS,Proto-oncogene c-Fos,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,48476,-0.00806877569772751,0.0122966714723457,-0.032170251783525,0.01603270038807,0.511718980642645
FOS,Proto-oncogene c-Fos,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",34922,0.0189341268420357,0.0165327808349492,-0.0134701235944647,0.0513383772785361,0.252154471229021
FOS,Proto-oncogene c-Fos,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",34922,0.00467475705618078,0.0171653063176572,-0.0289692433264274,0.0383187574387889,0.785372320791379
FOS,Proto-oncogene c-Fos,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",34922,0.00441944570822259,0.0245032812036937,-0.0436069854510172,0.0524458768674623,0.856875248736193
FOS,Proto-oncogene c-Fos,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",34922,0.0293942704614741,0.0100778392217838,0.00964170558677794,0.0491468353361703,0.00355103007924348
FOS,Proto-oncogene c-Fos,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",38654,-0.00725297760554768,0.00781195132304374,-0.0225644021987134,0.00805844698761805,0.353199779171286
FOS,Proto-oncogene c-Fos,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",38654,-0.0230250768415027,0.00918692179240879,-0.041031443554624,-0.0050187101283815,0.0122172484159032
FOS,Proto-oncogene c-Fos,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",38654,0.00488916120315013,0.00765256553553754,-0.0101098672465035,0.0198881896528037,0.522908804847521
FOS,Proto-oncogene c-Fos,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",38654,-0.0114066011732715,0.017602816663957,-0.0459081218346273,0.0230949194880843,0.517001559554684
FOS,Proto-oncogene c-Fos,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",38654,0.0233998578943595,0.00980096892507444,0.00418995880121362,0.0426097569875054,0.0169827059172187
FOS,Proto-oncogene c-Fos,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",38654,0.00403158099864895,0.0141589518803363,-0.0237199646868103,0.0317831266841082,0.775851683975995
FOS,Proto-oncogene c-Fos,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,48486,0.00503164601210649,0.0165115422363429,-0.0273309767711256,0.0373942687953386,0.760571222858413
FOS,Proto-oncogene c-Fos,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,48486,-0.0131627284648148,0.0125101052221692,-0.0376825347002663,0.0113570777706368,0.292735800646832
FOS,Proto-oncogene c-Fos,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,48486,0.0705902676079687,0.0333515703143764,0.00522118979179091,0.135959345424146,0.0343108222235039
FOS,Proto-oncogene c-Fos,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,48486,0.00831471723583191,0.0117145113713563,-0.0146457250520264,0.0312751595236902,0.477849609597034
FOS,Proto-oncogene c-Fos,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,48486,0.0012486617984153,0.013550090592016,-0.025309515761936,0.0278068393587666,0.926578591564324
FOS,Proto-oncogene c-Fos,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),48486,0.0193413032254838,0.0165606847195564,-0.0131176388248466,0.0518002452758143,0.242859599741462
FOS,Proto-oncogene c-Fos,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,48486,-0.00383680704023685,0.00555345940151647,-0.0147215874672091,0.00704797338673543,0.489645532580705
FOS,Proto-oncogene c-Fos,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,33956,0.00434974096404283,0.0136911820476017,-0.0224849758492566,0.0311844577773422,0.750723533126037
FOS,Proto-oncogene c-Fos,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,33956,-0.0056161969400732,0.0170906352604965,-0.0391138420506463,0.0278814481704998,0.742463020220898
FOS,Proto-oncogene c-Fos,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,33956,-0.0106782620169274,0.0118282782833871,-0.0338616874523662,0.0125051634185114,0.366691508477745
FOS,Proto-oncogene c-Fos,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,33956,-0.000219046903128962,0.0110983131587143,-0.021971740694209,0.0215336468879511,0.984254037703791
FOS,Proto-oncogene c-Fos,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,48563,-0.00125968579407738,0.00737648084157559,-0.0157175882435655,0.0131982166554108,0.864405959272787
FOS,Proto-oncogene c-Fos,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,48563,-0.0123356504379333,0.0207041886777553,-0.0529158602463338,0.0282445593704671,0.551312745598648
FOS,Proto-oncogene c-Fos,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,48563,-0.00509188148120221,0.00618527265653995,-0.0172150158880205,0.00703125292561608,0.410389234186671
FOS,Proto-oncogene c-Fos,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,48563,-0.00565829996413595,0.00595088667129079,-0.0173220378398659,0.006005437911594,0.341700976024212
FOS,Proto-oncogene c-Fos,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,48563,-0.000960084792363622,0.0101423425508502,-0.0208390761920301,0.0189189066073028,0.924585036026655
FOS,Proto-oncogene c-Fos,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,48563,-0.0107132515168507,0.00758504347509697,-0.0255799367280407,0.00415343369433939,0.157843002362859
FOS,Proto-oncogene c-Fos,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,48563,0.000607950179077047,0.00620760075347876,-0.0115589472977413,0.0127748476558954,0.92198379538238
FOS,Proto-oncogene c-Fos,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,48563,0.0531484150076113,0.0191507326796642,0.0156129789554696,0.0906838510597531,0.00552091229663076
FOS,Proto-oncogene c-Fos,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,42976,-0.000806093540462293,0.00653217716109948,-0.0136091607762173,0.0119969736952927,0.901789383186088
FOS,Proto-oncogene c-Fos,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,42976,0.00672901107476906,0.00679308762137679,-0.00658544066312945,0.0200434628126676,0.321914257974807
FOS,Proto-oncogene c-Fos,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,42976,-0.0154519960174397,0.00718394058119353,-0.029532519556579,-0.00137147247830035,0.0315007853010394
FOS,Proto-oncogene c-Fos,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,42976,0.00702385461221456,0.00974258766273386,-0.0120716172067438,0.0261193264311729,0.470956546284093
FOS,Proto-oncogene c-Fos,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,42976,-0.00717787610300863,0.00654924891975479,-0.020014403985728,0.00565865177971075,0.2731046549823
FOS,Proto-oncogene c-Fos,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,48379,-0.00731770665451017,0.00650252013942397,-0.0200626461277811,0.00542723281876081,0.26044859944262
FOS,Proto-oncogene c-Fos,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,48379,-0.00382057510599115,0.00528831220829361,-0.0141856670342466,0.00654451682226433,0.470022715876747
FOS,Proto-oncogene c-Fos,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,48379,-0.00771861772696568,0.00547726054971505,-0.0184540484044072,0.00301681295047581,0.158788891117152
FOS,Proto-oncogene c-Fos,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,48379,0.012220414295493,0.0119556529431394,-0.0112126654730603,0.0356534940640462,0.306725030670939
FOS,Proto-oncogene c-Fos,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),48394,-0.0122807688051814,0.00589287441995751,-0.0238308026682981,-0.000730734942064682,0.0371730700722992
FOS,Proto-oncogene c-Fos,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,48394,0.00983269285133748,0.011592299064793,-0.0128882133156567,0.0325535990183317,0.396332138108786
FOS,Proto-oncogene c-Fos,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),48486,-0.00761042178135621,0.00536251627991313,-0.018120953689986,0.00290011012727353,0.15586020518839
FOS,Proto-oncogene c-Fos,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,48486,0.0022130695020913,0.00612743665683666,-0.00979670634530855,0.0142228453494912,0.717973491305749
FOS,Proto-oncogene c-Fos,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,48486,-0.00789014026039811,0.00928793746211035,-0.0260944976861344,0.0103142171653382,0.395611432872479
FOS,Proto-oncogene c-Fos,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,48486,0.0279335155646844,0.0129204878201302,0.00260935943722919,0.0532576716921396,0.0306338859251657
FOS,Proto-oncogene c-Fos,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,48486,0.0147661415234003,0.0164439632198648,-0.0174640263875348,0.0469963094343353,0.369214180599422
FOS,Proto-oncogene c-Fos,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,48486,-0.0268991073276957,0.0151582641724467,-0.0566093051056912,0.00281109045029981,0.0759878807273903
FOS,Proto-oncogene c-Fos,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",40080,-0.00350310489373564,0.00365357032759606,-0.0106641027358239,0.00365789294835264,0.337672299181249
FOS,Proto-oncogene c-Fos,Physical activities,X864.Number of days or week walked 10+ minutes,48089,-0.0154853876541859,0.0376221636323777,-0.0892248283736462,0.0582540530652743,0.680635253754369
FOS,Proto-oncogene c-Fos,Physical activities,X874.Duration of walks,45516,0.00415424413215378,0.0029390428115693,-0.00160627977852205,0.00991476804282962,0.157537117830089
FOS,Proto-oncogene c-Fos,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,47282,-0.00550224694776555,0.0362662662236274,-0.0765841287460752,0.0655796348505441,0.879411018050742
FOS,Proto-oncogene c-Fos,Physical activities,X894.Duration of moderate activity,43222,0.0245525140747228,0.0443624221195704,-0.0623978332796351,0.111502861429081,0.579962100319645
FOS,Proto-oncogene c-Fos,Physical activities,X90087.No-wear time bias adjusted average acceleration,32790,-0.000287996193613065,0.00690898667914481,-0.0138296100847369,0.0132536176975108,0.966752693242276
FOS,Proto-oncogene c-Fos,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,47216,-0.0354124423182141,0.037250834901521,-0.108424078725195,0.037599194088767,0.341795701243275
FOS,Proto-oncogene c-Fos,Physical activities,X914.Duration of vigorous activity,38615,0.00505014520390757,0.00365142789417001,-0.00210665346866564,0.0122069438764808,0.166679133044778
